Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Molano Triviño, Alejandra Patricia"'
Autor:
Wancjer Meid, Benjamin, Molano Triviño, Alejandra Patricia, Perez-Fernandez, Oscar-Mauricio, Cantillo Manotas, Wainer
Publikováno v:
Eckardt K-U, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, et al. Evolving importance of kidney disease: from subspecialty to global health burden. The Lancet.382(9887):158-69.
James MT, Tonelli M, for the Alberta Kidney Disease N. Financial Aspects of Renal Replacement Therapy in Acute Kidney Injury. Seminars in Dialysis. 2011;24(2):215-9.
De Smedt DM, Elseviers MM, Lins RL, Annemans L. Economic evaluation of different treatment modalities in acute kidney injury. Nephrology Dialysis Transplantation. 2012;27(11):4095-101.
Kim IB, Fealy N, Baldwin I, Bellomo R. Premature Circuit Clotting due to Likely Mechanical Failure during Continuous Renal Replacement Therapy. Blood Purification. 2010;30(2):79-83.
Cutts MWJ, Thomas AN, Kishen R. Transfusion requirements during continuous veno-venous haemofiltration: – the importance of filter life. Intensive Care Medicine. 2000;26(11):1694-7.
Parienti J-J, Mégarbane B, Fischer M-O, Lautrette A, Gazui N, Marin N, et al. Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: A randomized controlled study. Critical Care Medicine. 2010;38(4).
Krouzecky A, Chvojka J, Sykora R, Radej J, Karvunidis T, Novak I, et al. Regional cooling of the extracorporeal blood circuit: a novel anticoagulation approach for renal replacement therapy? Intensive Care Medicine. 2009;35(2):364-70.
Bagshaw S, Davenport A. Cooling and reduced risk of clotting within the extracorporeal continuous renal replacement circuit. Intensive Care Medicine. 2009;35(2):195-7.
Baldwin I, Bellomo R, Koch B. Blood flow reductions during continuous renal replacement therapy and circuit life. Intensive Care Medicine. 2004;30(11):2074-9.
Baldwin I, Tan HK, Bridge N, Bellomo R. POSSIBLE STRATEGIES TO PROLONG CIRCUIT LIFE DURING HEMOFILTRATION: THREE CONTROLLED STUDIES. Renal Failure. 2002;24(6):839.
Nagarik Amit P SSS, Adikey Gopal Kishan, Raman Anuradha. Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy. Saudi J Kidney Dis Transpl. 2010;21(10):478-83.
Scribner BH CJ, Buri R, Quinton W. The technique of continuous hemodialysis. Trans Am Soc Artif Intern Organs. 1960;6:88-103.
Kidney D. Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney inter., Suppl.2012(2):1-138.
Li PKT, Burdmann EA, Mehta RL, for the World Kidney Day Steering Committee. Acute Kidney Injury: Global Health Alert. Transplantation. 2013;95(5):653-7.
Lameire NH, Bagga A, Cruz D, De Maeseneer J, Endre Z, Kellum JA, et al. Acute kidney injury: an increasing global concern. The Lancet.382(9887):170-9.
Schissler MM, Zaidi S, Kumar H, Deo D, Brier ME, McLeish KR. Characteristics and outcomes in community-acquired versus hospital-acquired acute kidney injury. Nephrology. 2013;18(3):183-7.
Finlay S, Bray B, Lewington AJ, Hunter-Rowe CT, Banerjee A, Atkinson JM, et al. Identification of risk factors associated with acute kidney injury in patients admitted to acute medical units. Clinical Medicine. 2013;13(3):238-88.
Wehbe E, Brock R, Budev M, Xu M, Demirjian S, Schreiber Jr MJ, et al. Short-term and long-term outcomes of acute kidney injury after lung transplantation. The Journal of Heart and Lung Transplantation. 2012;31(3):244-51.
Choi JS, Kim YA, Kim MJ, Kang YU, Kim CS, Bae EH, et al. Relation Between Transient or Persistent Acute Kidney Injury and Long-Term Mortality in Patients With Myocardial Infarction. The American Journal of Cardiology. 2013;112(1):41-5.
Schneider A, Bellomo R, Bagshaw S, Glassford N, Lo S, Jun M, et al. Choice of renal replacement therapy modality and dialysis dependence after acute kidney 47 injury: a systematic review and meta-analysis. Intensive Care Medicine. 2013;39(6):987-97.
Sanchez J, Maynar J, Herrera M. Terapias continuas de depuración extrarenal (TCDE). In: Poch E, Liaño F, Gaínza FJ, editors. MANEJO DE LA DISFUNCION AGUDA DEL RIÑON, del paciente critico en la practica clinica. 1. 1 ed. Madrid: Ergon; 2011. p. 69-86.
Davenport A, Neng K, Hertel J, Caruana R. anticoagulación. In: Daugirdas JT, editor. MANUAL DE DIALISIS. 1. 4 ed. Barcelona (España): Wolters Kluwer Health España S.A., Lippincott Williams & Wilkins; 2008 Copyrigth 2007 edicion en ingles. p. 203-15.
Lucchi L, Ligabue G, Marietta M, Delnevo A, Malagoli M, Perrone S, et al. Activation of Coagulation During Hemodialysis: Effect of Blood Lines Alone and Whole Extracorporeal Circuit. Artificial Organs. 2006;30(2):106-10.
Rebecca AC, Helen M, Ian JM, Samuel JM, Mervyn S. Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration. Kidney International. 1999;55(4):1568-74.
Gaínza FJ, Urbizu JM. Accesos vasculares, membranas y anticoagulacion extracorporea para tecnicas continuas o intermitentes en UCI. In: Poch E, Liaño F, Gaínza FJ, editors. MANEJO DE LA DISFUNCION AGUDA DEL RIÑON, del paciente critico en la practica clinica. 1. 1 ed. Madrid: Ergon; 2011. p. 55-68.
Oudemans-van Straaten HM. Citrate Anticoagulation for Continuous Renal Replacement Therapy in the Critically Ill. Blood Purification. 2010;29(2):191-6.
del Castillo J, Lopez-Herce J, Cidoncha E, Urbano J, Mencia S, Santiago M, et al. Circuit life span in critically ill children on continuous renal replacement treatment: a prospective observational evaluation study. Critical Care. 2008;12(4):R93.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
James MT, Tonelli M, for the Alberta Kidney Disease N. Financial Aspects of Renal Replacement Therapy in Acute Kidney Injury. Seminars in Dialysis. 2011;24(2):215-9.
De Smedt DM, Elseviers MM, Lins RL, Annemans L. Economic evaluation of different treatment modalities in acute kidney injury. Nephrology Dialysis Transplantation. 2012;27(11):4095-101.
Kim IB, Fealy N, Baldwin I, Bellomo R. Premature Circuit Clotting due to Likely Mechanical Failure during Continuous Renal Replacement Therapy. Blood Purification. 2010;30(2):79-83.
Cutts MWJ, Thomas AN, Kishen R. Transfusion requirements during continuous veno-venous haemofiltration: – the importance of filter life. Intensive Care Medicine. 2000;26(11):1694-7.
Parienti J-J, Mégarbane B, Fischer M-O, Lautrette A, Gazui N, Marin N, et al. Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: A randomized controlled study. Critical Care Medicine. 2010;38(4).
Krouzecky A, Chvojka J, Sykora R, Radej J, Karvunidis T, Novak I, et al. Regional cooling of the extracorporeal blood circuit: a novel anticoagulation approach for renal replacement therapy? Intensive Care Medicine. 2009;35(2):364-70.
Bagshaw S, Davenport A. Cooling and reduced risk of clotting within the extracorporeal continuous renal replacement circuit. Intensive Care Medicine. 2009;35(2):195-7.
Baldwin I, Bellomo R, Koch B. Blood flow reductions during continuous renal replacement therapy and circuit life. Intensive Care Medicine. 2004;30(11):2074-9.
Baldwin I, Tan HK, Bridge N, Bellomo R. POSSIBLE STRATEGIES TO PROLONG CIRCUIT LIFE DURING HEMOFILTRATION: THREE CONTROLLED STUDIES. Renal Failure. 2002;24(6):839.
Nagarik Amit P SSS, Adikey Gopal Kishan, Raman Anuradha. Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy. Saudi J Kidney Dis Transpl. 2010;21(10):478-83.
Scribner BH CJ, Buri R, Quinton W. The technique of continuous hemodialysis. Trans Am Soc Artif Intern Organs. 1960;6:88-103.
Kidney D. Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney inter., Suppl.2012(2):1-138.
Li PKT, Burdmann EA, Mehta RL, for the World Kidney Day Steering Committee. Acute Kidney Injury: Global Health Alert. Transplantation. 2013;95(5):653-7.
Lameire NH, Bagga A, Cruz D, De Maeseneer J, Endre Z, Kellum JA, et al. Acute kidney injury: an increasing global concern. The Lancet.382(9887):170-9.
Schissler MM, Zaidi S, Kumar H, Deo D, Brier ME, McLeish KR. Characteristics and outcomes in community-acquired versus hospital-acquired acute kidney injury. Nephrology. 2013;18(3):183-7.
Finlay S, Bray B, Lewington AJ, Hunter-Rowe CT, Banerjee A, Atkinson JM, et al. Identification of risk factors associated with acute kidney injury in patients admitted to acute medical units. Clinical Medicine. 2013;13(3):238-88.
Wehbe E, Brock R, Budev M, Xu M, Demirjian S, Schreiber Jr MJ, et al. Short-term and long-term outcomes of acute kidney injury after lung transplantation. The Journal of Heart and Lung Transplantation. 2012;31(3):244-51.
Choi JS, Kim YA, Kim MJ, Kang YU, Kim CS, Bae EH, et al. Relation Between Transient or Persistent Acute Kidney Injury and Long-Term Mortality in Patients With Myocardial Infarction. The American Journal of Cardiology. 2013;112(1):41-5.
Schneider A, Bellomo R, Bagshaw S, Glassford N, Lo S, Jun M, et al. Choice of renal replacement therapy modality and dialysis dependence after acute kidney 47 injury: a systematic review and meta-analysis. Intensive Care Medicine. 2013;39(6):987-97.
Sanchez J, Maynar J, Herrera M. Terapias continuas de depuración extrarenal (TCDE). In: Poch E, Liaño F, Gaínza FJ, editors. MANEJO DE LA DISFUNCION AGUDA DEL RIÑON, del paciente critico en la practica clinica. 1. 1 ed. Madrid: Ergon; 2011. p. 69-86.
Davenport A, Neng K, Hertel J, Caruana R. anticoagulación. In: Daugirdas JT, editor. MANUAL DE DIALISIS. 1. 4 ed. Barcelona (España): Wolters Kluwer Health España S.A., Lippincott Williams & Wilkins; 2008 Copyrigth 2007 edicion en ingles. p. 203-15.
Lucchi L, Ligabue G, Marietta M, Delnevo A, Malagoli M, Perrone S, et al. Activation of Coagulation During Hemodialysis: Effect of Blood Lines Alone and Whole Extracorporeal Circuit. Artificial Organs. 2006;30(2):106-10.
Rebecca AC, Helen M, Ian JM, Samuel JM, Mervyn S. Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration. Kidney International. 1999;55(4):1568-74.
Gaínza FJ, Urbizu JM. Accesos vasculares, membranas y anticoagulacion extracorporea para tecnicas continuas o intermitentes en UCI. In: Poch E, Liaño F, Gaínza FJ, editors. MANEJO DE LA DISFUNCION AGUDA DEL RIÑON, del paciente critico en la practica clinica. 1. 1 ed. Madrid: Ergon; 2011. p. 55-68.
Oudemans-van Straaten HM. Citrate Anticoagulation for Continuous Renal Replacement Therapy in the Critically Ill. Blood Purification. 2010;29(2):191-6.
del Castillo J, Lopez-Herce J, Cidoncha E, Urbano J, Mencia S, Santiago M, et al. Circuit life span in critically ill children on continuous renal replacement treatment: a prospective observational evaluation study. Critical Care. 2008;12(4):R93.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción: las terapias continuas de reemplazo renal son una importante medida a utilizar en los pacientes con lesión renal aguda que ingresan a la unidad de cuidado intensivo, la pérdida temprana del circuito por coagulación del mismo es una
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00182798518bc7aaf63e212e758ed967
http://repository.urosario.edu.co/handle/10336/10602
http://repository.urosario.edu.co/handle/10336/10602
Autor:
Ducuara Rodriguez, Daniel Humberto, Martínez Bernales, Anthony, Molano Triviño, Alejandra Patricia, Wancjer, Benjamín, Tovar Cuevas, José Rafael
Publikováno v:
Revista Ciencias de la Salud; Vol. 11, núm. 2 (2013); 173-183
Revista Ciencias de la Salud; Vol. 11, No. 2 (2013); 173-183
Revista Ciencias de la Salud; V. 11, n. 2 (2013); 173-183
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Revista Ciencias de la Salud; Vol. 11, No. 2 (2013); 173-183
Revista Ciencias de la Salud; V. 11, n. 2 (2013); 173-183
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Las guías KDOQI del año 2006 utilizan como estándar de adecuación para la diálisis el parámetroKt/V, donde V es el volumen de distribución de urea. Los pacientes con bajo peso tienen menorcantidad total de agua corporal total (menor V), de mod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::8d437b4b2c04c80ad1e3fbbb77273dbb
http://revistas.urosario.edu.co/index.php/revsalud/article/view/2680
http://revistas.urosario.edu.co/index.php/revsalud/article/view/2680
Publikováno v:
Kashiwagi T, Sato K, Kawakami S, Kiyomoto M, Enomoto M, Suzuki T, et al. Effects of reduced dialysis fluid flow in hemodialysis. J Nippon Med Sch [Internet]. 2013 [cited 2018 Sep 26];80(2):119–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23657065
Tarrass F, Benjelloun M, Benjelloun O. Recycling Wastewater After Hemodialysis: An Environmental Analysis for Alternative Water Sources in Arid Regions. Am J Kidney Dis. 2008;52(1):154–8.
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet [Internet]. 2013 Jul 20 [cited 2018 Sep 26];382(9888):260–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23727169
Prasad N, Jha V. Hemodialysis in Asia. Kidney Dis (Basel, Switzerland) [Internet]. 2015 Dec [cited 2018 Sep 26];1(3):165–77. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27536677
Hoenich NA, Levin R, Ronco C. Water for haemodialysis and related therapies: recent standards and emerging issues. Blood Purif. 2010;29(2):81–5.
Agar JWM. Reusing dialysis wastewater: the elephant in the room. Vol. 52, American journal of kidney diseases : the official journal of the National Kidney Foundation. United States; 2008. p. 10–2.
DAUGIRDAS JT. Prescribing and monitoring hemodialysis in a 3-4 × /week setting. Hemodial Int [Internet]. 2008 Apr [cited 2018 Sep 26];12(2):215–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18394053
Ronco C, La Manna G. Expanded Hemodialysis: A New Therapy for a New Class of Membranes. In: Contributions to nephrology [Internet]. 2017 [cited 2018 Sep 26]. p. 124–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28535525
Ducuara D, Martínez A, Molano A, Wancjer B, Tovar JR. Effect of flow adjustment dialysate (Qd) hemodialysis on effectiveness of underweight patients. [cited 2018 Sep 26]; Available from: https://www.ingentaconnect.com/content/doaj/16927273/2013/00000011/00000002/art00003#Refs
Molano Triviño A, Wancjer Meid B, Guzman G, Yunez Luqueta A, Beltrán J, Romero G, et al. SP491EFFECTS OF DECREASING DIALYSIS FLUID FLOW RATE ON DIALYSIS EFFICACY AND INTERDIALYTIC WEIGHT GAIN IN CHRONIC PATIENTS WITH HEMODIALYSIS-FLUGAIN Study. Nephrol Dial Transplant [Internet]. 2018 May 1 [cited 2018 Sep 26];33(suppl_1):i514–5. Available from: https://academic.oup.com/ndt/article/33/suppl_1/i514/4998454
Leypoldt JK, Prichard S, Chertow GM, Alvarez L. Differential Molecular Modeling Predictions of Mid and Conventional Dialysate Flows. Blood Purif. 2019;47(4):369–76.
Molano Trivino A, Galván Á, Wancjer Meid B, Vesga J, Suárez A, Sanabria RM, et al. SAT-342 LONG TERM OUTCOMES OF LOWERING DIALYSATE FLOW (QD) IN A POPULATION OF CHRONIC HEMODIALYSIS IN RTS COLOMBIA. Kidney Int Reports [Internet]. 2019 Jul 1;4(7):S151–2. Available from: https://doi.org/10.1016/j.ekir.2019.05.390
Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the Hemodialysis Prescription on Patient Morbidity. N Engl J Med [Internet]. 1981 Nov 12 [cited 2018 Sep 26];305(20):1176–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7027040
Harter HR. Review of significant findings from the National Cooperative Dialysis Study and recommendations. Kidney Int Suppl [Internet]. 1983 Apr [cited 2018 Sep 26];(13):S107-12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6345891
Vanholder R, Schepers E, Pletinck A, Nagler E V., Glorieux G. The Uremic Toxicity of Indoxyl Sulfate and p-Cresyl Sulfate: A Systematic Review. J Am Soc Nephrol [Internet]. 2014 Sep 1 [cited 2018 Sep 26];25(9):1897–907. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24812165
Locatelli F, Martin-Malo A, Hannedouche T, Loureiro A, Papadimitriou M, Wizemann V, et al. Effect of Membrane Permeability on Survival of Hemodialysis Patients. J Am Soc Nephrol [Internet]. 2009 Feb 25 [cited 2018 Sep 26];20(3):645–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19092122
Hakim P discussant: RM. Assessing the adequacy of dialysis. Kidney Int [Internet]. 1990 Feb 1;37(2):822–32. Available from: https://doi.org/10.1038/ki.1990.52
Hemodialysis Adequacy 2006 Work Group. Clinical Practice Guidelines for Hemodialysis Adequacy, Update 2006. Am J Kidney Dis [Internet]. 2006 Jul [cited 2018 Sep 26];48:S2–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16813990
Goldstein SL, Brem A, Warady BA, Fivush B, Frankenfield D. Comparison of single-pool and equilibrated Kt/V values for pediatric hemodialysis prescription management: analysis from the Centers for Medicare & Medicaid Services Clinical Performance Measures Project. Pediatr Nephrol. 2006 Aug;21(8):1161–6.
Himmelfarb J, Ikizler TA. Hemodialysis. N Engl J Med [Internet]. 2010 Nov 3;363(19):1833–45. Available from: https://doi.org/10.1056/NEJMra0902710
Daugirdas JT, Depner TA. A nomogram approach to hemodialysis urea modeling. Am J Kidney Dis [Internet]. 1994 Jan [cited 2018 Sep 26];23(1):33–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8285195
Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol [Internet]. 1993 Nov [cited 2018 Sep 26];4(5):1205–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8305648
Besarab A, Sherman R. The relationship of recirculation to access blood flow. Am J Kidney Dis [Internet]. 1997 Feb [cited 2018 Sep 26];29(2):223–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9016893
Eloot S, Van Biesen W, Vanholder R. A Sad but Forgotten Truth: The Story of Slow-Moving Solutes in Fast Hemodialysis. Semin Dial [Internet]. 2012 Sep 1 [cited 2018 Sep 26];25(5):505–9. Available from: http://doi.wiley.com/10.1111/j.1525-139X.2012.01107.x
European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association. Section II. Haemodialysis adequacy. Nephrol Dial Transplant [Internet]. 2002 [cited 2018 Sep 26];17 Suppl 7:16–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12386211
Glorieux G, Tattersall J. Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacy. Clin Kidney J [Internet]. 2015 Aug [cited 2018 Sep 26];8(4):353–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26251699
Vanholder R, Glorieux G, Eloot S. Once upon a time in dialysis: the last days of Kt/V? Kidney Int [Internet]. 2015 Sep [cited 2018 Sep 26];88(3):460–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26061543
Powers KM, Wilkowski MJ, Helmandollar AW, Koenig KG, Bolton WK. Improved urea reduction ratio and Kt/V in large hemodialysis patients using two dialyzers in parallel. Am J Kidney Dis [Internet]. 2000 Feb [cited 2018 Sep 26];35(2):266–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10676726
el Akrout M, Jadoul M. [Methodology and practical use in hemodialysis of the percentage of urea reduction (PUR)]. Nephrologie [Internet]. 1995 [cited 2018 Sep 26];16(6):413–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8524448
Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The Urea Reduction Ratio and Serum Albumin Concentration as Predictors of Mortality in Patients Undergoing Hemodialysis. N Engl J Med [Internet]. 1993 Sep 30 [cited 2018 Sep 26];329(14):1001–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8366899
Held PJ, Port FK, Wolfe RA, Stannard DC, Carroll CE, Daugirdas JT, et al. The dose of hemodialysis and patient mortality. Kidney Int [Internet]. 1996 Aug [cited 2018 Sep 26];50(2):550–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8840285
Sehgal AR, Snow RJ, Singer ME, Amini SB, DeOreo PB, Silver MR, et al. Barriers to adequate delivery of hemodialysis. Am J Kidney Dis [Internet]. 1998 Apr [cited 2018 Sep 26];31(4):593–601. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9531174
Ifudu O, Mayers JD, Matthew JJ, Fowler AM, Homel P, Friedman EA. Standardized Hemodialysis Prescriptions Promote Inadequate Treatment in Patients with Large Body Mass. Ann Intern Med [Internet]. 1998 Mar 15 [cited 2018 Sep 26];128(6):451. Available from: http://annals.org/article.aspx?doi=10.7326/0003-4819-128-6-199803150-00005
Alayoud A, Benyahia M, Montassir D, Hamzi A, Zajjari Y, Bahadi A, et al. A Model to Predict Optimal Dialysate Flow. Ther Apher Dial [Internet]. 2012 Apr [cited 2018 Sep 26];16(2):152–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22458394
Bhimani JP, Ouseph R, Ward RA. Effect of increasing dialysate flow rate on diffusive mass transfer of urea, phosphate and 2-microglobulin during clinical haemodialysis. Nephrol Dial Transplant [Internet]. 2010 Dec 1 [cited 2018 Sep 26];25(12):3990–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20543211
Yamamoto K-I, Matsukawa H, Yakushiji T, Fukuda M, Hiyoshi T, Sakai K. Technical Evaluation of Dialysate Flow in a Newly Designed Dialyzer. ASAIO J [Internet]. 2007 Jan [cited 2018 Sep 26];53(1):36–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17237647
Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003 May;63(5):1934–43.
Ronco C. The Rise of Expanded Hemodialysis. Vol. 44, Blood purification. Switzerland; 2017. p. I–VIII.
Cuenta de alto costo. Situación de la enfermedad renal crónica, la hipertensión arterial y la diabetes mellitus. Cuenta alto costo [Internet]. 2017;280. Available from: https://cuentadealtocosto.org/site/images/Publicaciones/2018/Libro_Situacion_ERC_en_Colombia_2017.pdf
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Tarrass F, Benjelloun M, Benjelloun O. Recycling Wastewater After Hemodialysis: An Environmental Analysis for Alternative Water Sources in Arid Regions. Am J Kidney Dis. 2008;52(1):154–8.
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet [Internet]. 2013 Jul 20 [cited 2018 Sep 26];382(9888):260–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23727169
Prasad N, Jha V. Hemodialysis in Asia. Kidney Dis (Basel, Switzerland) [Internet]. 2015 Dec [cited 2018 Sep 26];1(3):165–77. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27536677
Hoenich NA, Levin R, Ronco C. Water for haemodialysis and related therapies: recent standards and emerging issues. Blood Purif. 2010;29(2):81–5.
Agar JWM. Reusing dialysis wastewater: the elephant in the room. Vol. 52, American journal of kidney diseases : the official journal of the National Kidney Foundation. United States; 2008. p. 10–2.
DAUGIRDAS JT. Prescribing and monitoring hemodialysis in a 3-4 × /week setting. Hemodial Int [Internet]. 2008 Apr [cited 2018 Sep 26];12(2):215–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18394053
Ronco C, La Manna G. Expanded Hemodialysis: A New Therapy for a New Class of Membranes. In: Contributions to nephrology [Internet]. 2017 [cited 2018 Sep 26]. p. 124–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28535525
Ducuara D, Martínez A, Molano A, Wancjer B, Tovar JR. Effect of flow adjustment dialysate (Qd) hemodialysis on effectiveness of underweight patients. [cited 2018 Sep 26]; Available from: https://www.ingentaconnect.com/content/doaj/16927273/2013/00000011/00000002/art00003#Refs
Molano Triviño A, Wancjer Meid B, Guzman G, Yunez Luqueta A, Beltrán J, Romero G, et al. SP491EFFECTS OF DECREASING DIALYSIS FLUID FLOW RATE ON DIALYSIS EFFICACY AND INTERDIALYTIC WEIGHT GAIN IN CHRONIC PATIENTS WITH HEMODIALYSIS-FLUGAIN Study. Nephrol Dial Transplant [Internet]. 2018 May 1 [cited 2018 Sep 26];33(suppl_1):i514–5. Available from: https://academic.oup.com/ndt/article/33/suppl_1/i514/4998454
Leypoldt JK, Prichard S, Chertow GM, Alvarez L. Differential Molecular Modeling Predictions of Mid and Conventional Dialysate Flows. Blood Purif. 2019;47(4):369–76.
Molano Trivino A, Galván Á, Wancjer Meid B, Vesga J, Suárez A, Sanabria RM, et al. SAT-342 LONG TERM OUTCOMES OF LOWERING DIALYSATE FLOW (QD) IN A POPULATION OF CHRONIC HEMODIALYSIS IN RTS COLOMBIA. Kidney Int Reports [Internet]. 2019 Jul 1;4(7):S151–2. Available from: https://doi.org/10.1016/j.ekir.2019.05.390
Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the Hemodialysis Prescription on Patient Morbidity. N Engl J Med [Internet]. 1981 Nov 12 [cited 2018 Sep 26];305(20):1176–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7027040
Harter HR. Review of significant findings from the National Cooperative Dialysis Study and recommendations. Kidney Int Suppl [Internet]. 1983 Apr [cited 2018 Sep 26];(13):S107-12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6345891
Vanholder R, Schepers E, Pletinck A, Nagler E V., Glorieux G. The Uremic Toxicity of Indoxyl Sulfate and p-Cresyl Sulfate: A Systematic Review. J Am Soc Nephrol [Internet]. 2014 Sep 1 [cited 2018 Sep 26];25(9):1897–907. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24812165
Locatelli F, Martin-Malo A, Hannedouche T, Loureiro A, Papadimitriou M, Wizemann V, et al. Effect of Membrane Permeability on Survival of Hemodialysis Patients. J Am Soc Nephrol [Internet]. 2009 Feb 25 [cited 2018 Sep 26];20(3):645–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19092122
Hakim P discussant: RM. Assessing the adequacy of dialysis. Kidney Int [Internet]. 1990 Feb 1;37(2):822–32. Available from: https://doi.org/10.1038/ki.1990.52
Hemodialysis Adequacy 2006 Work Group. Clinical Practice Guidelines for Hemodialysis Adequacy, Update 2006. Am J Kidney Dis [Internet]. 2006 Jul [cited 2018 Sep 26];48:S2–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16813990
Goldstein SL, Brem A, Warady BA, Fivush B, Frankenfield D. Comparison of single-pool and equilibrated Kt/V values for pediatric hemodialysis prescription management: analysis from the Centers for Medicare & Medicaid Services Clinical Performance Measures Project. Pediatr Nephrol. 2006 Aug;21(8):1161–6.
Himmelfarb J, Ikizler TA. Hemodialysis. N Engl J Med [Internet]. 2010 Nov 3;363(19):1833–45. Available from: https://doi.org/10.1056/NEJMra0902710
Daugirdas JT, Depner TA. A nomogram approach to hemodialysis urea modeling. Am J Kidney Dis [Internet]. 1994 Jan [cited 2018 Sep 26];23(1):33–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8285195
Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol [Internet]. 1993 Nov [cited 2018 Sep 26];4(5):1205–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8305648
Besarab A, Sherman R. The relationship of recirculation to access blood flow. Am J Kidney Dis [Internet]. 1997 Feb [cited 2018 Sep 26];29(2):223–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9016893
Eloot S, Van Biesen W, Vanholder R. A Sad but Forgotten Truth: The Story of Slow-Moving Solutes in Fast Hemodialysis. Semin Dial [Internet]. 2012 Sep 1 [cited 2018 Sep 26];25(5):505–9. Available from: http://doi.wiley.com/10.1111/j.1525-139X.2012.01107.x
European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association. Section II. Haemodialysis adequacy. Nephrol Dial Transplant [Internet]. 2002 [cited 2018 Sep 26];17 Suppl 7:16–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12386211
Glorieux G, Tattersall J. Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacy. Clin Kidney J [Internet]. 2015 Aug [cited 2018 Sep 26];8(4):353–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26251699
Vanholder R, Glorieux G, Eloot S. Once upon a time in dialysis: the last days of Kt/V? Kidney Int [Internet]. 2015 Sep [cited 2018 Sep 26];88(3):460–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26061543
Powers KM, Wilkowski MJ, Helmandollar AW, Koenig KG, Bolton WK. Improved urea reduction ratio and Kt/V in large hemodialysis patients using two dialyzers in parallel. Am J Kidney Dis [Internet]. 2000 Feb [cited 2018 Sep 26];35(2):266–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10676726
el Akrout M, Jadoul M. [Methodology and practical use in hemodialysis of the percentage of urea reduction (PUR)]. Nephrologie [Internet]. 1995 [cited 2018 Sep 26];16(6):413–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8524448
Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The Urea Reduction Ratio and Serum Albumin Concentration as Predictors of Mortality in Patients Undergoing Hemodialysis. N Engl J Med [Internet]. 1993 Sep 30 [cited 2018 Sep 26];329(14):1001–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8366899
Held PJ, Port FK, Wolfe RA, Stannard DC, Carroll CE, Daugirdas JT, et al. The dose of hemodialysis and patient mortality. Kidney Int [Internet]. 1996 Aug [cited 2018 Sep 26];50(2):550–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8840285
Sehgal AR, Snow RJ, Singer ME, Amini SB, DeOreo PB, Silver MR, et al. Barriers to adequate delivery of hemodialysis. Am J Kidney Dis [Internet]. 1998 Apr [cited 2018 Sep 26];31(4):593–601. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9531174
Ifudu O, Mayers JD, Matthew JJ, Fowler AM, Homel P, Friedman EA. Standardized Hemodialysis Prescriptions Promote Inadequate Treatment in Patients with Large Body Mass. Ann Intern Med [Internet]. 1998 Mar 15 [cited 2018 Sep 26];128(6):451. Available from: http://annals.org/article.aspx?doi=10.7326/0003-4819-128-6-199803150-00005
Alayoud A, Benyahia M, Montassir D, Hamzi A, Zajjari Y, Bahadi A, et al. A Model to Predict Optimal Dialysate Flow. Ther Apher Dial [Internet]. 2012 Apr [cited 2018 Sep 26];16(2):152–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22458394
Bhimani JP, Ouseph R, Ward RA. Effect of increasing dialysate flow rate on diffusive mass transfer of urea, phosphate and 2-microglobulin during clinical haemodialysis. Nephrol Dial Transplant [Internet]. 2010 Dec 1 [cited 2018 Sep 26];25(12):3990–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20543211
Yamamoto K-I, Matsukawa H, Yakushiji T, Fukuda M, Hiyoshi T, Sakai K. Technical Evaluation of Dialysate Flow in a Newly Designed Dialyzer. ASAIO J [Internet]. 2007 Jan [cited 2018 Sep 26];53(1):36–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17237647
Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003 May;63(5):1934–43.
Ronco C. The Rise of Expanded Hemodialysis. Vol. 44, Blood purification. Switzerland; 2017. p. I–VIII.
Cuenta de alto costo. Situación de la enfermedad renal crónica, la hipertensión arterial y la diabetes mellitus. Cuenta alto costo [Internet]. 2017;280. Available from: https://cuentadealtocosto.org/site/images/Publicaciones/2018/Libro_Situacion_ERC_en_Colombia_2017.pdf
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción: Actualmente se dispone de dializadores con membranas cuyos poros han expandido la capacidad de aclaramiento de moléculas medianas, permitiendo desarrollar un nuevo concepto de terapia: “Hemodiálisis Expandida”. Se ha demostrado a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6d6ed78c73a3b3d0b7c4b7d3aa55e29
https://repository.urosario.edu.co/handle/10336/20859
https://repository.urosario.edu.co/handle/10336/20859
Autor:
Yucumá Gutiérrez, Samuel
Publikováno v:
Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco AL, De Jong PE, et al. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements. 2013;3(1):1-150
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción: La enfermedad renal crónica al presentar falla renal severa requiere de tratamientos complejos con terapias de sustitución (diálisis o trasplante). Para determinar la eficacia de estas terapias se realiza mensualmente el cálculo de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a136f5b422fe5d040d25f1a034268fc
Autor:
Galván Marín, Ángel Rolando
Publikováno v:
Thakur S, Rao SN. Effects of Reduced Dialysis Fluid Flow in Hemodialysis. Igarss 2014. 2014;(1):1-5. doi:10.1007/s13398-014-0173-7.2.
World Kidney Day 2015; http://www.worldkidneyday.org/faqs/chronic-kidney-disease/.
Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. Jul 20 2013;382(9888):260-272.
Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. Dec 2011;80(12):1258-1270.
Connor A, Lillywhite R, Cooke MW. The carbon footprints of home and in-center maintenance hemodialysis in the United Kingdom. Hemodial Int. 2011 Jan;15(1):39-51. doi: 10.1111/j.1542-4758.2010.00523. x. Epub 2011 Jan 14
Daugirdas JT. Bases fisiológicas y modelo cinético de la urea. Manual de diálisis. 4ta ed. Madrid: Lippincott and Wilkins; 2007.
Nissenson AR, Fine RN. Modelo cinético de la urea como guía terapéutica de hemodiálisis en adultos. Manual de diálisis. 4ta ed. Madrid: Elsevier Masson; 2008.
Ward AR, Idoux WJ, Ouseph R, Depner T, Golper T. Dialysate flow rate and delivered Kt/V urea fordialyzers with enhanced dialysate flow distribution. Clinical J SocNeph 2011; 6: 2235-9.
Ouseph R, Ward AR. Increasing dialysate flow rate increases dialyzer urea mass transfer-area coefficients during clinical use. Am J Kidney Dis 2001; 37 (2): 316-20.
Bhimani JP, Ouseph R, Ward RA. Effect of increasing dialysate flow rate on diffusive mass transfer of urea, phosphate and β2-microglobulin during clinical haemodialysis. Nephrol Dial Transplant 2010; 25 (12): 3990-5.
Leypoldt J, Craig D. Kamerath, Janice F. Gilson, And Goetz Friederichs Dialyzer Clearances and Mass Transfer-Area Coefficients for Small Solutes at Low Dialysate Flow Rates, ASAIO Journal 2007 DOI: 10.1097/01.mat.0000245525.83936.79
Asar AT. Increasing dialysate flow rate increases dyalizer urea clearence and dialysis efficiency: an in vivo study. Saudi J Kidney Dis Transpl 2009; 6 (20): 1023-9.
Alayoud A, Benyahia M, Montassir D, Hamzi A, Zajjari Y, Bahadi A, El Kabbaj D et al. A model to predict optimal dialysate flow. Therap Apheresis Dial 2012; 16 (2): 152-8.
Ducuara D, Molano A, Yunez A, Wancjer B, Effect of flow adjustment dialysate (Qd) hemodialysis on effectiveness of underweight patients, Revista Ciencias de la Salud 11(2):173-183 · August 2013
Ahrenholz P, Roland E. Winkler, Diego Zendeh-Zartochti The role of the dialysate flow rate in haemodialysisBioArt Products GmbH Rostock, 2: Praxis verbundDialyse und Apherese Rostock, September 2013 DOI: 10.5772/58878
Yamamoto K, Matsukawa H, Yakushiji T, Technical Evaluation of Dialysate Flow in a Newly Designed Dialyzer, ASAIO Journal 2007; 53:36-40.
Agar JWM, Simmonds RE, Knight R, Somerville CA. Using water wisely: New, affordable, and essential water conservation practices for facility and home hemodialysis. Hemodial Int. 2009;13(1):32-37. doi:10.1111/j.1542-4758.2009.00332.x.
World Health Organization. Guidelines for drinking-water quality: recommendations. Vol. 1. World Health Organization, 2004.
Agar JWM. Green Dialysis: The Environmental Challenges A head. Semin Dial. 2015;28(2):186-192. doi:10.1111/sdi.12324.
Sanabria M, Moreno J, Vesga J, Astudillo K, Bunch A, et al. Mortalidad observada versus esperada en una red de unidades de diálisis en Colombia. Acta Médica Colombiana 2017;42:106-111.
Otero GA, De Francisco A, Gayoso P, García F. Prevalencia de la insuficiencia renal crónica en España: Resultados del estudio EPIRCE. Nefrología. 2010;30(01):78-86.
Wagner M, et al. Predicting Mortality in Incident Dialysis Patients: An Analysis of the United Kingdom Renal Registry. Am J Kidney Dis. 2011;57(6):894-902.
Pérez-García, Rafael, et al. "Estudio epidemiológico de 7316 pacientes en hemodiálisis tratados en las clínicas Fresenius Medical Care de España, con los datos obtenidos mediante la base de datos EuCliD®: resultados de los años 2009-2010." Nefrología (Madrid) 32.6 (2012): 743-753.
Kashiwagi, Tetsuya, et al. "Effects of reduced dialysis fluid flow in hemodialysis." Journal of Nippon Medical School 80.2 (2013): 119-130.
Brattich M. Morbidity and mortality in patients on dialysis: the impact of hemoglobin levels. Nephrol Nursing J. 2006;33(1):6469.
Concepción-Zavaleta, Marcio, et al. "Factores de riesgo asociados a mortalidad en pacientes con enfermedad renal crónica terminal." Rev Soc Peru Med Interna 28.2 (2015): 72-8.
de Mutsert, Renée, et al. "Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition." Journal of renal nutrition 19.2 (2009): 127-135.
Gonzalez-Bedat, María Carlota, Guillermo Rosa-Diez, and Alejandro Ferreiro. "El Registro Latinoamericano de Diálisis y Trasplante Renal: la importancia del desarrollo de los registros nacionales en Latinoamérica." Nefrología Latinoamericana 14.1 (2017): 12-21.
Evans, Philip D., and Maarten W. Taal. "Epidemiology and causes of chronic kidney disease." Medicine 39.7 (2011): 402-406.
Rivillas, Juan C., et al. "Envejecimiento poblacional y desigualdades sociales en la mortalidad del adulto mayor en Colombia¿ Por qué abordarlos ahora y dónde comenzar?." Facultad Nacional de Salud Pública: El escenario para la salud pública desde la ciencia 35.3 (2017): 10.
Weng, Cheng-Hao, et al. "Nutritional predictors of mortality in long term hemodialysis patients." Scientific reports 6 (2016): 35639.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
World Kidney Day 2015; http://www.worldkidneyday.org/faqs/chronic-kidney-disease/.
Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. Jul 20 2013;382(9888):260-272.
Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. Dec 2011;80(12):1258-1270.
Connor A, Lillywhite R, Cooke MW. The carbon footprints of home and in-center maintenance hemodialysis in the United Kingdom. Hemodial Int. 2011 Jan;15(1):39-51. doi: 10.1111/j.1542-4758.2010.00523. x. Epub 2011 Jan 14
Daugirdas JT. Bases fisiológicas y modelo cinético de la urea. Manual de diálisis. 4ta ed. Madrid: Lippincott and Wilkins; 2007.
Nissenson AR, Fine RN. Modelo cinético de la urea como guía terapéutica de hemodiálisis en adultos. Manual de diálisis. 4ta ed. Madrid: Elsevier Masson; 2008.
Ward AR, Idoux WJ, Ouseph R, Depner T, Golper T. Dialysate flow rate and delivered Kt/V urea fordialyzers with enhanced dialysate flow distribution. Clinical J SocNeph 2011; 6: 2235-9.
Ouseph R, Ward AR. Increasing dialysate flow rate increases dialyzer urea mass transfer-area coefficients during clinical use. Am J Kidney Dis 2001; 37 (2): 316-20.
Bhimani JP, Ouseph R, Ward RA. Effect of increasing dialysate flow rate on diffusive mass transfer of urea, phosphate and β2-microglobulin during clinical haemodialysis. Nephrol Dial Transplant 2010; 25 (12): 3990-5.
Leypoldt J, Craig D. Kamerath, Janice F. Gilson, And Goetz Friederichs Dialyzer Clearances and Mass Transfer-Area Coefficients for Small Solutes at Low Dialysate Flow Rates, ASAIO Journal 2007 DOI: 10.1097/01.mat.0000245525.83936.79
Asar AT. Increasing dialysate flow rate increases dyalizer urea clearence and dialysis efficiency: an in vivo study. Saudi J Kidney Dis Transpl 2009; 6 (20): 1023-9.
Alayoud A, Benyahia M, Montassir D, Hamzi A, Zajjari Y, Bahadi A, El Kabbaj D et al. A model to predict optimal dialysate flow. Therap Apheresis Dial 2012; 16 (2): 152-8.
Ducuara D, Molano A, Yunez A, Wancjer B, Effect of flow adjustment dialysate (Qd) hemodialysis on effectiveness of underweight patients, Revista Ciencias de la Salud 11(2):173-183 · August 2013
Ahrenholz P, Roland E. Winkler, Diego Zendeh-Zartochti The role of the dialysate flow rate in haemodialysisBioArt Products GmbH Rostock, 2: Praxis verbundDialyse und Apherese Rostock, September 2013 DOI: 10.5772/58878
Yamamoto K, Matsukawa H, Yakushiji T, Technical Evaluation of Dialysate Flow in a Newly Designed Dialyzer, ASAIO Journal 2007; 53:36-40.
Agar JWM, Simmonds RE, Knight R, Somerville CA. Using water wisely: New, affordable, and essential water conservation practices for facility and home hemodialysis. Hemodial Int. 2009;13(1):32-37. doi:10.1111/j.1542-4758.2009.00332.x.
World Health Organization. Guidelines for drinking-water quality: recommendations. Vol. 1. World Health Organization, 2004.
Agar JWM. Green Dialysis: The Environmental Challenges A head. Semin Dial. 2015;28(2):186-192. doi:10.1111/sdi.12324.
Sanabria M, Moreno J, Vesga J, Astudillo K, Bunch A, et al. Mortalidad observada versus esperada en una red de unidades de diálisis en Colombia. Acta Médica Colombiana 2017;42:106-111.
Otero GA, De Francisco A, Gayoso P, García F. Prevalencia de la insuficiencia renal crónica en España: Resultados del estudio EPIRCE. Nefrología. 2010;30(01):78-86.
Wagner M, et al. Predicting Mortality in Incident Dialysis Patients: An Analysis of the United Kingdom Renal Registry. Am J Kidney Dis. 2011;57(6):894-902.
Pérez-García, Rafael, et al. "Estudio epidemiológico de 7316 pacientes en hemodiálisis tratados en las clínicas Fresenius Medical Care de España, con los datos obtenidos mediante la base de datos EuCliD®: resultados de los años 2009-2010." Nefrología (Madrid) 32.6 (2012): 743-753.
Kashiwagi, Tetsuya, et al. "Effects of reduced dialysis fluid flow in hemodialysis." Journal of Nippon Medical School 80.2 (2013): 119-130.
Brattich M. Morbidity and mortality in patients on dialysis: the impact of hemoglobin levels. Nephrol Nursing J. 2006;33(1):6469.
Concepción-Zavaleta, Marcio, et al. "Factores de riesgo asociados a mortalidad en pacientes con enfermedad renal crónica terminal." Rev Soc Peru Med Interna 28.2 (2015): 72-8.
de Mutsert, Renée, et al. "Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition." Journal of renal nutrition 19.2 (2009): 127-135.
Gonzalez-Bedat, María Carlota, Guillermo Rosa-Diez, and Alejandro Ferreiro. "El Registro Latinoamericano de Diálisis y Trasplante Renal: la importancia del desarrollo de los registros nacionales en Latinoamérica." Nefrología Latinoamericana 14.1 (2017): 12-21.
Evans, Philip D., and Maarten W. Taal. "Epidemiology and causes of chronic kidney disease." Medicine 39.7 (2011): 402-406.
Rivillas, Juan C., et al. "Envejecimiento poblacional y desigualdades sociales en la mortalidad del adulto mayor en Colombia¿ Por qué abordarlos ahora y dónde comenzar?." Facultad Nacional de Salud Pública: El escenario para la salud pública desde la ciencia 35.3 (2017): 10.
Weng, Cheng-Hao, et al. "Nutritional predictors of mortality in long term hemodialysis patients." Scientific reports 6 (2016): 35639.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Antecedentes: La hemodiálisis requiere una gran cantidad de agua. Con el desarrollo de los nuevos filtros de alta eficiencia la depuración de moléculas depende en menor grado de la velocidad del líquido QD lo que permitiría prescribir menores ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b63686d3bea7987348881f1b441cffeb
Autor:
Doria, Cesar, Cantillo, Wainer
Publikováno v:
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción: La enfermedad renal crónica es un factor independiente de riesgo cardiovascular y a su vez la enfermedad coronaria es un predictor de mortalidad en la población en diálisis. Materiales y métodos: Cohorte histórica de pacientes may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f603ef9d79e727175b459899f8788349
http://repository.urosario.edu.co/handle/10336/14185
http://repository.urosario.edu.co/handle/10336/14185
Publikováno v:
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción: No hay conocimiento a nivel local (Latinoamérica o Colombia) de la problemática real de la prevalencia de hiperparatiroidismo secundario (HPT2) en pacientes en diálisis que es una población creciente a nivel mundial por el aumento
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cb4c22160107c66c26595a978db420f
http://repository.urosario.edu.co/handle/10336/14200
http://repository.urosario.edu.co/handle/10336/14200
Publikováno v:
Granata A, Clementi A, Virzi GM, Brocca A, de Cal M, Scarfia VR, et al. Cardiorenal syndrome type 4: From chronic kidney disease to cardiovascular impairment. European journal of internal medicine. 2016.
Casado Cerrada J, Perez Calvo JI. [Organ damage and cardiorenal syndrome in acute heart failure]. Medicina clinica. 2014;142 Suppl 1:26-31.
Nunez J, Minana G, Santas E, Bertomeu-Gonzalez V. Cardiorenal Syndrome in Acute Heart Failure: Revisiting Paradigms. Revista espanola de cardiologia (English ed). 2015;68(5):426-35.
Pai P. Cardiorenal syndrome. Hong Kong Journal of Nephrology. 2015;17(2):36-45.
Adriaan A. Voors et al. 2016 Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal (2016) 37, 2129 – 2200.
Montenegro Jesus.Tratado de Dialisis Peritoneal. Elsevier España.2015.
I-Kuan Wang et al. Permanent Cardiac Pacing in patients with end-stage renal disease undergoing dialysis.Nephrol Dial Transplant; 31:2115-2122.
Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, et al. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. Eur Heart J. 2010; 31:703-11.
Fonarow ;ADHERE Scientific Advisory Committee: The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 2003; 4:S21–S30.
Schrier RW: Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 2006; 47: 1–8.
Renhua Lu. Peritoneal Dialysis in Patients with Refractory Congestive Heart Failure: A Systematic Review. Cardiorenal Med 2015;5: 145–156.
Adachi Y, Nakagawa Y, Nishio A. Icodextrine preserves residual renal function in patients treated with automated peritoneal dialysis.Perit Dial Int 2006; 26:405.
Uchino S, Doig GS, Bellomo R, et al. Diuretics and mortality in acute renal failure. Crit Care Med 2004; 32:1669-1677.
Hidaka H, Nakao T.Preservation of residual renal function and factors affecting its decline in patients on peritoneal dialysis.Nephrology.2003 Aug;8(4):184-91
Mistry CD, Gokal R, Peers E. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group (1994) Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. Kidney Int 46:496–503
Smith GL, Shlipak MG, Havranek EP et al. Race and renal impairment in heart failure: mortality in blacks versus whites. Circulation 2005; 111: 1270–1277.
Hanna Fröhlich. Peritoneal ultrafiltration in end-stage chronic heart failure. Clin Kidney J (2015) 8: 219–225
Constanzo MR, Saltzberg M, O'Sullivan J, et al. Early ultrafiltration in patients with descompensated heart failure and diuretic resistance. J Am Coll Cardiol 2005; 46:2047-51.
Rajapakse NW, Nanayakkara S, Kaye DM. Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairment. Pharmacology & therapeutics. 2015;154:1-12.
Scabbia EV, Scabbia L. The Cardio-renal Syndrome (CRS). IJC Metabolic & Endocrine. 2015;9:1-4.
Clementi A, Virzi GM, Brocca A, de Cal M, Pastori S, Clementi M, et al. Advances in the pathogenesis of cardiorenal syndrome type 3. Oxidative medicine and cellular longevity. 2015;2015:148082
Chuasuwan A, Kellum JA. Cardio-renal syndrome type 3: epidemiology, pathophysiology, and treatment. Seminars in nephrology. 2012;32(1):31-9.
Clementi A, Virzi GM, Goh CY, Cruz DN, Granata A, Vescovo G, et al. Cardiorenal syndrome type 4: a review. Cardiorenal medicine. 2013;3(1):63-70.
Clementi A, Virzi GM, Brocca A, de Cal M, Vescovo G, Granata A, et al. Cardiorenal syndrome type 4: management. Blood purification. 2013;36(3-4):200-9.
Brocca A, Virzi GM, Pasqualin C, Pastori S, Marcante S, de Cal M, et al. Cardiorenal syndrome type 5: in vitro cytotoxicity effects on renal tubular cells and inflammatory profile. Analytical cellular pathology (Amsterdam). 2015;2015:469461.
Giusto Viglino et al. Peritoneal ultrafiltration in congestive heart failure-findings reported from its application in clinical practice: a systematic review. J Nephrol (2015) 28:29–38.
Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, et al. NHLBI Heart Failure Clinical Research Network. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011; 364:797-805.
Domansky M, Norman J, Pitt B, Haigney M, Hanlon S, Peyster E. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 2003; 42:705-708.
Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS, Schollmeyer MP, Sobotka PA. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007;49:675-83.
Silvio V. Bertoli. Peritoneal ultrafiltration in refractory heart failure: a cohort study Cécile Courivaud, peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics. Peritoneal Dialysis International2014, Vol. 34, pp. 100–108.
Karlien Francois. Peritoneal Dialysis for Chronic Congestive Heart Failure. Blood Purif 2015; 40:45–52.
Jessup M et al.: 2009 focused update: ACCF/AHA Guidelines for the Diagnosis andManagement of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119: 1977–2016.
Fonarow;ADHERE Scientific Advisory Committee: The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 2003; 4:S21–S30.
Eknoyan G, Beck GJ, Cheung AK, et al. Hemodialysis (HEMO) Study Group. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347:2010e2019.
Bart BA, Goldsmith SR, Lee KL, Givertz MM, O’Connor CM, Bull DA, Redfield MM, Deswal A, Rouleau JL, LeWinter MM, Ofili EO Stevenson LW, Semigran MJ, Felker GM, Chen HH, Hernandez AF,Anstrom KJ, McNulty SE, Velazquez EJ, Ibarra JC, Mascette AM, Braunwald E. Ultrafiltration in decompensated heart 22 failure with cardiorenal syndrome. N Engl J Med 2012; 367: 2296-2304 [PMID:23131078 DOI: 10.1056/NEJMoa1210357]
Paniagua R, Amato D, Vonesh E, et al. Mexican Nephrology Collaborative Study Group. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13:1307e1320.
Van Biesen W, Lameire N, Verbeke F, et al. Residual renal function and volume status in peritoneal dialysis patients: a conflict of interest? J Nephrol 2008; 21:299e304.
Amir kasory et al.Peritoneal dialysis for chronic cardiorenal syndrome: Lessons learned from ultrafiltration trials, World J Cardiol 2015 July 26; 7(7): 392-396.
Bakris GL, Ritz E, World Kidney Day Steering Committee. The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented. J Am Soc Hypertens 2009; 3 : 80e83.
Moist LM, Port FK, Orzol SM, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000; 11:556e564.
Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT; NECOSAD Study Group. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol. 2004; 15 (4):1061–1070.
Ronco C, Cicoira M, McCullough PA. Cardiorenal syndrome type pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure.J Am Coll Cardiol 2012;60:10314.
Cruz DN et al: Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the acute dialysis quality initiative (ADQI). Contrib Nephrol 2013; 182: 117–136.
Morduchowicz G, Winkler J, Zabludowski JR, Boner G: Effects of residual function in haemodialysis patients. Int Urol Nephrol 26:125-31, 1994.
Giusto Viglino et al. Peritoneal ultrafiltration in congestive heart failure-findings reported from its application in clinical practice: a systematic review. J Nephrol (2015) 28:29–38
Borrego F, Selga R, de Álvaro F, Bajo MA et al. Seguimiento de la función renal residual en pacientes en DPCA. La influencia de los aclaramientos peritoneales y de los fármacos. Nefrología. 1993; 13(1):37-46
Wolfson M, Piraino B, Hamburger RJ et al (2002) A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis 40:1055–1065
Altmann P, Butler KC, Flowman D: Residual renal function in hemodialysis patients may protect against hyperaluminemia. Kidney Int 32: 710-3, 1987.
Smith GL, Shlipak MG, Havranek EP et al. Race and renal impairment in heart failure: mortality in blacks versus whites. Circulation 2005;111: 1270–1277.
Bergman JM, Thorpe KE, Churchill DN; CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12(10):2158–2162.
Holley JL, Aslam N, Bernardini J, Fried L, Piraino B. The influence of demographic factor and modality on loss of residual renal function in incident peritoneal dialysis patients. Peritoneal Dialysis International 2001 Perit Dial Int. 2001 May-Jun;21(3):302-5.
Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998;9(Suppl.12):S16-S23.
Tian SL, Tian XK, Han QF, Axelsson J, Wang T. Presence of peripheral arterial disease predicts loss of residual renal function in incident CAPD patients Perit Dial Int. 2012 Jan-Feb;32(1):67-72.
Hung AM, Young BS, Chertow GM. The decline in residual renal function in hemodialysis is slow and age dependent. Hemodial Int. 2003 Jan 1;7(1):17-22.
Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, Rogers NL, Teschan PE. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int. 1997 Jun;51(6):1908-19
Cnossen TT, Kooman JP, Konings CJ, Uszko-Lencer NH, Leunissen KM, van der Sande FM. Peritoneal dialysis in patients with primary cardiac failure complicated by renal failure. Blood Purif. 2010; 30(2):146-52.
Courivaud C, Kazory A, Crépin T, Azar R, Bresson-Vautrin C, Chalopin JM, Ducloux D. Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics. Perit Dial Int. 2014 Jan-Feb; 34(1):100-8
Liao CT, Chen YM, Shiao CC, Hu FC, Huang JW, Kao TW, et al. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis. Nephrol Dial Transplant 2009; 24:2909-14.
Sheppard R, Panyon J, Pohwani AL, Kapoor A, Macgowan G, McNamara D, Mathier M, Johnston JR, Murali S. Intermittent outpatient ultrafiltration for the treatment of severe refractory congestive heart failure. J Card Fail. 2004 Oct; 10(5):380-3.
Koch M, Haastert B, Kohnle M, Rump LC, Kelm M, Trapp R, Aker S. Peritoneal dialysis relieves clinical symptoms and is well tolerated in patients with refractory heart failure and chronic kidney disease. Eur J Heart Fail. 2012 May; 14(5):530-9.
USRDS. Table H.29. Mortality rates by primary cause of mortality, unadjusted. In: USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End Stage Renal Disease in the U.S. Bethesda, MD: National Institutes of Health: National Institute of Diabetes Digestive and Kidney Diseases; 2007: H.29.
Abilash Koratala, Ankur Jain. Ultrafiltration does provide more efficient decongestion compared to conventiona for acute heart failure.International Journal Of Cardiology; December 27, 2016.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Casado Cerrada J, Perez Calvo JI. [Organ damage and cardiorenal syndrome in acute heart failure]. Medicina clinica. 2014;142 Suppl 1:26-31.
Nunez J, Minana G, Santas E, Bertomeu-Gonzalez V. Cardiorenal Syndrome in Acute Heart Failure: Revisiting Paradigms. Revista espanola de cardiologia (English ed). 2015;68(5):426-35.
Pai P. Cardiorenal syndrome. Hong Kong Journal of Nephrology. 2015;17(2):36-45.
Adriaan A. Voors et al. 2016 Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal (2016) 37, 2129 – 2200.
Montenegro Jesus.Tratado de Dialisis Peritoneal. Elsevier España.2015.
I-Kuan Wang et al. Permanent Cardiac Pacing in patients with end-stage renal disease undergoing dialysis.Nephrol Dial Transplant; 31:2115-2122.
Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, et al. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. Eur Heart J. 2010; 31:703-11.
Fonarow ;ADHERE Scientific Advisory Committee: The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 2003; 4:S21–S30.
Schrier RW: Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 2006; 47: 1–8.
Renhua Lu. Peritoneal Dialysis in Patients with Refractory Congestive Heart Failure: A Systematic Review. Cardiorenal Med 2015;5: 145–156.
Adachi Y, Nakagawa Y, Nishio A. Icodextrine preserves residual renal function in patients treated with automated peritoneal dialysis.Perit Dial Int 2006; 26:405.
Uchino S, Doig GS, Bellomo R, et al. Diuretics and mortality in acute renal failure. Crit Care Med 2004; 32:1669-1677.
Hidaka H, Nakao T.Preservation of residual renal function and factors affecting its decline in patients on peritoneal dialysis.Nephrology.2003 Aug;8(4):184-91
Mistry CD, Gokal R, Peers E. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group (1994) Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. Kidney Int 46:496–503
Smith GL, Shlipak MG, Havranek EP et al. Race and renal impairment in heart failure: mortality in blacks versus whites. Circulation 2005; 111: 1270–1277.
Hanna Fröhlich. Peritoneal ultrafiltration in end-stage chronic heart failure. Clin Kidney J (2015) 8: 219–225
Constanzo MR, Saltzberg M, O'Sullivan J, et al. Early ultrafiltration in patients with descompensated heart failure and diuretic resistance. J Am Coll Cardiol 2005; 46:2047-51.
Rajapakse NW, Nanayakkara S, Kaye DM. Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairment. Pharmacology & therapeutics. 2015;154:1-12.
Scabbia EV, Scabbia L. The Cardio-renal Syndrome (CRS). IJC Metabolic & Endocrine. 2015;9:1-4.
Clementi A, Virzi GM, Brocca A, de Cal M, Pastori S, Clementi M, et al. Advances in the pathogenesis of cardiorenal syndrome type 3. Oxidative medicine and cellular longevity. 2015;2015:148082
Chuasuwan A, Kellum JA. Cardio-renal syndrome type 3: epidemiology, pathophysiology, and treatment. Seminars in nephrology. 2012;32(1):31-9.
Clementi A, Virzi GM, Goh CY, Cruz DN, Granata A, Vescovo G, et al. Cardiorenal syndrome type 4: a review. Cardiorenal medicine. 2013;3(1):63-70.
Clementi A, Virzi GM, Brocca A, de Cal M, Vescovo G, Granata A, et al. Cardiorenal syndrome type 4: management. Blood purification. 2013;36(3-4):200-9.
Brocca A, Virzi GM, Pasqualin C, Pastori S, Marcante S, de Cal M, et al. Cardiorenal syndrome type 5: in vitro cytotoxicity effects on renal tubular cells and inflammatory profile. Analytical cellular pathology (Amsterdam). 2015;2015:469461.
Giusto Viglino et al. Peritoneal ultrafiltration in congestive heart failure-findings reported from its application in clinical practice: a systematic review. J Nephrol (2015) 28:29–38.
Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, et al. NHLBI Heart Failure Clinical Research Network. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011; 364:797-805.
Domansky M, Norman J, Pitt B, Haigney M, Hanlon S, Peyster E. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 2003; 42:705-708.
Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS, Schollmeyer MP, Sobotka PA. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007;49:675-83.
Silvio V. Bertoli. Peritoneal ultrafiltration in refractory heart failure: a cohort study Cécile Courivaud, peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics. Peritoneal Dialysis International2014, Vol. 34, pp. 100–108.
Karlien Francois. Peritoneal Dialysis for Chronic Congestive Heart Failure. Blood Purif 2015; 40:45–52.
Jessup M et al.: 2009 focused update: ACCF/AHA Guidelines for the Diagnosis andManagement of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119: 1977–2016.
Fonarow;ADHERE Scientific Advisory Committee: The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 2003; 4:S21–S30.
Eknoyan G, Beck GJ, Cheung AK, et al. Hemodialysis (HEMO) Study Group. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347:2010e2019.
Bart BA, Goldsmith SR, Lee KL, Givertz MM, O’Connor CM, Bull DA, Redfield MM, Deswal A, Rouleau JL, LeWinter MM, Ofili EO Stevenson LW, Semigran MJ, Felker GM, Chen HH, Hernandez AF,Anstrom KJ, McNulty SE, Velazquez EJ, Ibarra JC, Mascette AM, Braunwald E. Ultrafiltration in decompensated heart 22 failure with cardiorenal syndrome. N Engl J Med 2012; 367: 2296-2304 [PMID:23131078 DOI: 10.1056/NEJMoa1210357]
Paniagua R, Amato D, Vonesh E, et al. Mexican Nephrology Collaborative Study Group. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13:1307e1320.
Van Biesen W, Lameire N, Verbeke F, et al. Residual renal function and volume status in peritoneal dialysis patients: a conflict of interest? J Nephrol 2008; 21:299e304.
Amir kasory et al.Peritoneal dialysis for chronic cardiorenal syndrome: Lessons learned from ultrafiltration trials, World J Cardiol 2015 July 26; 7(7): 392-396.
Bakris GL, Ritz E, World Kidney Day Steering Committee. The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented. J Am Soc Hypertens 2009; 3 : 80e83.
Moist LM, Port FK, Orzol SM, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000; 11:556e564.
Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT; NECOSAD Study Group. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol. 2004; 15 (4):1061–1070.
Ronco C, Cicoira M, McCullough PA. Cardiorenal syndrome type pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure.J Am Coll Cardiol 2012;60:10314.
Cruz DN et al: Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the acute dialysis quality initiative (ADQI). Contrib Nephrol 2013; 182: 117–136.
Morduchowicz G, Winkler J, Zabludowski JR, Boner G: Effects of residual function in haemodialysis patients. Int Urol Nephrol 26:125-31, 1994.
Giusto Viglino et al. Peritoneal ultrafiltration in congestive heart failure-findings reported from its application in clinical practice: a systematic review. J Nephrol (2015) 28:29–38
Borrego F, Selga R, de Álvaro F, Bajo MA et al. Seguimiento de la función renal residual en pacientes en DPCA. La influencia de los aclaramientos peritoneales y de los fármacos. Nefrología. 1993; 13(1):37-46
Wolfson M, Piraino B, Hamburger RJ et al (2002) A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis 40:1055–1065
Altmann P, Butler KC, Flowman D: Residual renal function in hemodialysis patients may protect against hyperaluminemia. Kidney Int 32: 710-3, 1987.
Smith GL, Shlipak MG, Havranek EP et al. Race and renal impairment in heart failure: mortality in blacks versus whites. Circulation 2005;111: 1270–1277.
Bergman JM, Thorpe KE, Churchill DN; CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12(10):2158–2162.
Holley JL, Aslam N, Bernardini J, Fried L, Piraino B. The influence of demographic factor and modality on loss of residual renal function in incident peritoneal dialysis patients. Peritoneal Dialysis International 2001 Perit Dial Int. 2001 May-Jun;21(3):302-5.
Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998;9(Suppl.12):S16-S23.
Tian SL, Tian XK, Han QF, Axelsson J, Wang T. Presence of peripheral arterial disease predicts loss of residual renal function in incident CAPD patients Perit Dial Int. 2012 Jan-Feb;32(1):67-72.
Hung AM, Young BS, Chertow GM. The decline in residual renal function in hemodialysis is slow and age dependent. Hemodial Int. 2003 Jan 1;7(1):17-22.
Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, Rogers NL, Teschan PE. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int. 1997 Jun;51(6):1908-19
Cnossen TT, Kooman JP, Konings CJ, Uszko-Lencer NH, Leunissen KM, van der Sande FM. Peritoneal dialysis in patients with primary cardiac failure complicated by renal failure. Blood Purif. 2010; 30(2):146-52.
Courivaud C, Kazory A, Crépin T, Azar R, Bresson-Vautrin C, Chalopin JM, Ducloux D. Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics. Perit Dial Int. 2014 Jan-Feb; 34(1):100-8
Liao CT, Chen YM, Shiao CC, Hu FC, Huang JW, Kao TW, et al. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis. Nephrol Dial Transplant 2009; 24:2909-14.
Sheppard R, Panyon J, Pohwani AL, Kapoor A, Macgowan G, McNamara D, Mathier M, Johnston JR, Murali S. Intermittent outpatient ultrafiltration for the treatment of severe refractory congestive heart failure. J Card Fail. 2004 Oct; 10(5):380-3.
Koch M, Haastert B, Kohnle M, Rump LC, Kelm M, Trapp R, Aker S. Peritoneal dialysis relieves clinical symptoms and is well tolerated in patients with refractory heart failure and chronic kidney disease. Eur J Heart Fail. 2012 May; 14(5):530-9.
USRDS. Table H.29. Mortality rates by primary cause of mortality, unadjusted. In: USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End Stage Renal Disease in the U.S. Bethesda, MD: National Institutes of Health: National Institute of Diabetes Digestive and Kidney Diseases; 2007: H.29.
Abilash Koratala, Ankur Jain. Ultrafiltration does provide more efficient decongestion compared to conventiona for acute heart failure.International Journal Of Cardiology; December 27, 2016.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción: La ICC que deteriora la función renal es denominada SCR. La DP se plantea como alternativa que impacta en la función cardíaca, hospitalización, síntomas e incluso en la mortalidad 3-5 . Objetivo: Describir el comportamiento de la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7259fe3034ba9a787e748f194c8e32a8
Autor:
Ucrós Lozano, Enrique Carlos
Publikováno v:
Yesid C, Lombo J, Correa I, Quintero N. Características clínicas y demográficas de los pacientes incidentes en diálisis crónica y su relación con el ingreso programado a diálisis. Acta Medica Colombiana [Internet]. 20013;138–42. Available from: http://www.redalyc.org/articulo.oa?id=163128381009
Nielsen AL, Jensen HA, Hegbrant J, Brinkenfeldt H, Thunedborg P. Oxygen status during haemodialysis. The Cord-Group. Acta Anaesthesiol Scand Suppl [Internet]. 1995;107:195–200. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8599277
Pedersen T, Dyrlund Pedersen B, Møller AM. Pulse oximetry for perioperative monitoring. Cochrane database Syst Rev [Internet]. 2003;(3):CD002013. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12917918
Mengelkoch LJ, Martin D, Lawler J. A review of the principles of pulse oximetry and accuracy of pulse oximeter estimates during exercise. Phys Ther [Internet]. 1994 Jan;74(1):40–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8265727
Avitsian R, Abdelmalak B, Saad S, Xu M, O’Hara J. Upper extremity arteriovenous fistula does not affect pulse oximetry readings. Nephrology (Carlton) [Internet]. 2006 Oct;11(5):410–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17014554
Lin G, Kais H, Halpern Z, Chayen D, Weissgarten J, Negri M, et al. Pulse oxymetry evaluation of oxygen saturation in the upper extremity with an arteriovenous fistula before and during hemodialysis. Am J Kidney Dis [Internet]. 1997 Feb;29(2):230–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9016894
Kober A, Scheck T, Lieba F, Barker R, Vlach W, Schramm W, et al. The influence of active warming on signal quality of pulse oximetry in prehospital trauma care. Anesth Analg [Internet]. 2002 Oct;95(4):961–6, table of contents. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12351277
Reich DL, Timcenko A, Bodian CA, Kraidin J, Hofman J, DePerio M, et al. Predictors of pulse oximetry data failure. Anesthesiology [Internet]. 1996 36 Apr;84(4):859–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8638840
Kurki TS, Smith NT, Sanford TJ, Head N. Pulse oximetry and finger blood pressure measurement during open-heart surgery. J Clin Monit [Internet]. 1989 Oct;5(4):221– 8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2809666
Martínez-Castelao A, Gorriz JL, Bover J, Segura-de la Morena J, Cebollada J, Escalada J, et al. Documento de consenso para la deteccion y manejo de la enfermedad renal crónica. Aten Primaria [Internet]. 2014;46(9):501–19. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24658201
Gilmore J. KDOQI clinical practice guidelines and clinical practice recommendations--2006 updates. Nephrol Nurs J [Internet]. 33(5):487–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17044433
Levey AS, Coresh J. Chronic kidney disease. Lancet (London, England) [Internet]. 2012 Jan 14;379(9811):165–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21840587
Andrassy KM. Comments on “KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease”. Kidney Int [Internet]. 2013 Sep;84(3):622–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23989362
House AA, Ronco C. The burden of cardiovascular risk in chronic kidney disease and dialysis patients (cardiorenal syndrome type 4). Contrib Nephrol [Internet]. 2011;171:50–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21625089
Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med [Internet]. 2004 Mar 22;164(6):659–63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15037495
Frankel A. Temporary access and central venous catheters. Eur J Vasc Endovasc Surg [Internet]. 2006 Apr;31(4):417–22. Available from: 37 http://www.ncbi.nlm.nih.gov/pubmed/16360326
Amorim P, Sousa G, Vieira J, Sousa L, Ribeiro K, Sobrinho G, et al. [Complications of vascular access for hemodialysis-limits, imagination and commitment]. Rev Port Cir cardio-torácica e Vasc órgão Of da Soc Port Cir Cardio-Torácica e Vasc [Internet]. 20(4):211–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25202756
Yerdel MA, Kesenci M, Yazicioglu KM, Döşeyen Z, Türkçapar AG, Anadol E. Effect of haemodynamic variables on surgically created arteriovenous fistula flow. Nephrol Dial Transplant [Internet]. 1997 Aug;12(8):1684–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9269649
Robbin ML, Chamberlain NE, Lockhart ME, Gallichio MH, Young CJ, Deierhoi MH, et al. Hemodialysis arteriovenous fistula maturity: US evaluation. Radiology [Internet]. 2002 Oct;225(1):59–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12354984
Bashar K, Healy D, Browne LD, Kheirelseid EAH, Walsh MT, Clarke-Moloney M, et al. Role of far infra-red therapy in dialysis arterio-venous fistula maturation and survival: systematic review and meta-analysis. PLoS One [Internet]. 2014;9(8):e104931. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25115802
Santoro A, Canova C, Freyrie A, Mancini E. Vascular access for hemodialysis. J Nephrol [Internet]. 19(3):259–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16874684
Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int [Internet]. 2002 Oct;62(4):1109–24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12234281
Lok CE, Oliver MJ, Su J, Bhola C, Hannigan N, Jassal S V. Arteriovenous fistula outcomes in the era of the elderly dialysis population. Kidney Int [Internet]. 2005 Jun;67(6):2462–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15882293
Rayner HC, Pisoni RL, Gillespie BW, Goodkin DA, Akiba T, Akizawa T, et al. Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int [Internet]. 2003 Jan;63(1):323– 30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12472799
Rayner HC, Besarab A, Brown WW, Disney A, Saito A, Pisoni RL. Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines. Am J Kidney Dis [Internet]. 2004 Nov;44(5 Suppl 2):22–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15486870
Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, et al. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int [Internet]. 2002 Jan;61(1):305–16. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11786113
Allon M, Lockhart ME, Lilly RZ, Gallichio MH, Young CJ, Barker J, et al. Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients. Kidney Int [Internet]. 2001 Nov;60(5):2013–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11703621
Oliver MJ, McCann RL, Indridason OS, Butterly DW, Schwab SJ. Comparison of transposed brachiobasilic fistulas to upper arm grafts and brachiocephalic fistulas. Kidney Int [Internet]. 2001 Oct;60(4):1532–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11576369
Allon M. Current management of vascular access. Clin J Am Soc Nephrol [Internet]. 2007 Jul;2(4):786–800. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17699495
Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol [Internet]. 2004 Feb;15(2):477–86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14747396
End Stage Renal Disease Network Organization Program 2012 Summary Annual 39 Report [Internet]. Baltimore,: Centers for Medicare & Medicaid Services; 2014. Available from: http://esrdncc.org/wpcontent/ uploads/2014/10/SAR2012_FINAL_10_07_14.pdf
USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [Internet]. Bethesda: U.S. Renal Data System; 2010. Available from: http://www.usrds.org/adr.aspx
USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [Internet]. Bethesda: U.S. Renal Data System,; 2012. Available from: http://www.usrds.org/atlas12.aspx
Conte MS, Nugent HM, Gaccione P, Roy-Chaudhury P, Lawson JH. Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling. J Vasc Surg [Internet]. 2011 Nov;54(5):1383–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21840154
Salmela B, Hartman J, Peltonen S, Albäck A, Lassila R. Thrombophilia and arteriovenous fistula survival in ESRD. Clin J Am Soc Nephrol [Internet]. 2013 Jun;8(6):962–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23411429
Peterson WJ, Barker J, Allon M. Disparities in fistula maturation persist despite preoperative vascular mapping. Clin J Am Soc Nephrol [Internet]. 2008 Mar;3(2):437–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18235150
Rodriguez JA, Armadans L, Ferrer E, Olmos A, Codina S, Bartolomé J, et al. The function of permanent vascular access. Nephrol Dial Transplant [Internet]. 2000 Mar;15(3):402–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10692528
Lee T, Ullah A, Allon M, Succop P, El-Khatib M, Munda R, et al. Decreased cumulative access survival in arteriovenous fistulas requiring interventions to promote maturation. Clin J Am Soc Nephrol [Internet]. 2011 Mar;6(3):575–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21088288
Allon M, Litovsky S, Young CJ, Deierhoi MH, Goodman J, Hanaway M, et al. Medial fibrosis, vascular calcification, intimal hyperplasia, and arteriovenous fistula maturation. Am J Kidney Dis [Internet]. 2011 Sep;58(3):437–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21719173
Khavanin Zadeh M, Gholipour F, Naderpour Z, Porfakharan M. Relationship between Vessel Diameter and Time to Maturation of Arteriovenous Fistula for Hemodialysis Access. Int J Nephrol [Internet]. 2012;2012:942950. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22187645
Khavanin Zadeh M, Gholipour F, Hadipour R. The effect of hemoglobin level on arteriovenous fistula survival in Iranian hemodialysis patients. J Vasc Access [Internet]. 9(2):133–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18609530
Yilmaz H, Bozkurt A, Cakmak M, Celik HT, Bilgic MA, Bavbek N, et al. Relationship between late arteriovenous fistula (AVF) stenosis and neutrophillymphocyte ratio (NLR) in chronic hemodialysis patients. Ren Fail [Internet]. 2014 Oct;36(9):1390–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25246339
Acuña Merchán L, Soler Vanoy LA. Situación de la Enfermedad Renal Crónica en Colombia 2013 [Internet]. Bogotá: Cuenta de Alto Costo; 2013. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/INEC/CAC/SIT UACION_DE_LA_ENFERMEDAD_RENAL_CRONICA_2013.pdf
Jubran. Pulse oximetry. Crit Care [Internet]. 1999;3(2):R11–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11094477
Wukitsch MW, Petterson MT, Tobler DR, Pologe JA. Pulse oximetry: analysis of theory, technology, and practice. J Clin Monit [Internet]. 1988 Oct;4(4):290–301. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3057122
Wouters PF, Gehring H, Meyfroidt G, Ponz L, Gil-Rodriguez J, Hornberger C, et al. Accuracy of pulse oximeters: the European multi-center trial. Anesth Analg [Internet]. 2002 Jan;94(1 Suppl):S13–6. Available from: 41 http://www.ncbi.nlm.nih.gov/pubmed/11900030
Van de Louw A, Cracco C, Cerf C, Harf A, Duvaldestin P, Lemaire F, et al. Accuracy of pulse oximetry in the intensive care unit. Intensive Care Med [Internet]. 2001 Oct;27(10):1606–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17999668
Pulse oximeters. Health Devices [Internet]. 1989 Jun;18(6):185–99, 206–19, 222–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2485835
Clayton DG, Webb RK, Ralston AC, Duthie D, Runciman WB. Pulse oximeter probes. A comparison between finger, nose, ear and forehead probes under conditions of poor perfusion. Anaesthesia [Internet]. 1991 Apr;46(4):260–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2024741
Branson RD, Mannheimer PD. Forehead oximetry in critically ill patients: the case for a new monitoring site. Respir Care Clin N Am [Internet]. 2004 Sep;10(3):359– 67, vi – vii. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15458733
Fernandez M, Burns K, Calhoun B, George S, Martin B, Weaver C. Evaluation of a new pulse oximeter sensor. Am J Crit Care [Internet]. 2007 Mar;16(2):146–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17322015
Schallom L, Sona C, McSweeney M, Mazuski J. Comparison of forehead and digit oximetry in surgical/trauma patients at risk for decreased peripheral perfusion. Heart Lung [Internet]. 36(3):188–94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17509425
Ralston AC, Webb RK, Runciman WB. Potential errors in pulse oximetry. I. Pulse oximeter evaluation. Anaesthesia [Internet]. 1991 Mar;46(3):202–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2014898
Jubran A, Tobin MJ. Reliability of pulse oximetry in titrating supplemental oxygen therapy in ventilator-dependent patients. Chest [Internet]. 1990 Jun;97(6):1420–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2347228
Saito S, Fukura H, Shimada H, Fujita T. Prolonged interference of blue dye “patent blue” with pulse oximetry readings. Acta Anaesthesiol Scand [Internet]. 1995 Feb;39(2):268–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7793197
Comber JT, Lopez BL. Evaluation of pulse oximetry in sickle cell anemia patients presenting to the emergency department in acute vasoocclusive crisis. Am J Emerg Med [Internet]. 1996 Jan;14(1):16–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8630147
Coté CJ, Goldstein EA, Fuchsman WH, Hoaglin DC. The effect of nail polish on pulse oximetry. Anesth Analg [Internet]. 1988 Jul;67(7):683–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3382042
Rheineck-Leyssius AT, Kalkman CJ. Influence of pulse oximeter lower alarm limit on the incidence of hypoxaemia in the recovery room. Br J Anaesth [Internet]. 1997 Oct;79(4):460–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9389263
Le Bourdellès G, Estagnasié P, Lenoir F, Brun P, Dreyfuss D. Use of a pulse oximeter in an adult emergency department: impact on the number of arterial blood gas analyses ordered. Chest [Internet]. 1998 Apr;113(4):1042–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9554645
Solsona JF, Marrugat J, Vázquez A, Masdeu G, Alvárez F, Nolla J. Effect of pulse oximetry on clinical practice in the intensive care unit. Lancet (London, England) [Internet]. 1993 Jul 31;342(8866):311–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8101343
Jubran A. Pulse oximetry. Crit Care [Internet]. 2015;19:272. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26179876
No Title [Internet]. Available from: http://urgenciaspediatria.hospitalcruces.com/doc/generales/proto/Cap4.6_pulsioxime tria.pdf
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Nielsen AL, Jensen HA, Hegbrant J, Brinkenfeldt H, Thunedborg P. Oxygen status during haemodialysis. The Cord-Group. Acta Anaesthesiol Scand Suppl [Internet]. 1995;107:195–200. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8599277
Pedersen T, Dyrlund Pedersen B, Møller AM. Pulse oximetry for perioperative monitoring. Cochrane database Syst Rev [Internet]. 2003;(3):CD002013. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12917918
Mengelkoch LJ, Martin D, Lawler J. A review of the principles of pulse oximetry and accuracy of pulse oximeter estimates during exercise. Phys Ther [Internet]. 1994 Jan;74(1):40–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8265727
Avitsian R, Abdelmalak B, Saad S, Xu M, O’Hara J. Upper extremity arteriovenous fistula does not affect pulse oximetry readings. Nephrology (Carlton) [Internet]. 2006 Oct;11(5):410–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17014554
Lin G, Kais H, Halpern Z, Chayen D, Weissgarten J, Negri M, et al. Pulse oxymetry evaluation of oxygen saturation in the upper extremity with an arteriovenous fistula before and during hemodialysis. Am J Kidney Dis [Internet]. 1997 Feb;29(2):230–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9016894
Kober A, Scheck T, Lieba F, Barker R, Vlach W, Schramm W, et al. The influence of active warming on signal quality of pulse oximetry in prehospital trauma care. Anesth Analg [Internet]. 2002 Oct;95(4):961–6, table of contents. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12351277
Reich DL, Timcenko A, Bodian CA, Kraidin J, Hofman J, DePerio M, et al. Predictors of pulse oximetry data failure. Anesthesiology [Internet]. 1996 36 Apr;84(4):859–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8638840
Kurki TS, Smith NT, Sanford TJ, Head N. Pulse oximetry and finger blood pressure measurement during open-heart surgery. J Clin Monit [Internet]. 1989 Oct;5(4):221– 8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2809666
Martínez-Castelao A, Gorriz JL, Bover J, Segura-de la Morena J, Cebollada J, Escalada J, et al. Documento de consenso para la deteccion y manejo de la enfermedad renal crónica. Aten Primaria [Internet]. 2014;46(9):501–19. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24658201
Gilmore J. KDOQI clinical practice guidelines and clinical practice recommendations--2006 updates. Nephrol Nurs J [Internet]. 33(5):487–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17044433
Levey AS, Coresh J. Chronic kidney disease. Lancet (London, England) [Internet]. 2012 Jan 14;379(9811):165–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21840587
Andrassy KM. Comments on “KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease”. Kidney Int [Internet]. 2013 Sep;84(3):622–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23989362
House AA, Ronco C. The burden of cardiovascular risk in chronic kidney disease and dialysis patients (cardiorenal syndrome type 4). Contrib Nephrol [Internet]. 2011;171:50–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21625089
Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med [Internet]. 2004 Mar 22;164(6):659–63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15037495
Frankel A. Temporary access and central venous catheters. Eur J Vasc Endovasc Surg [Internet]. 2006 Apr;31(4):417–22. Available from: 37 http://www.ncbi.nlm.nih.gov/pubmed/16360326
Amorim P, Sousa G, Vieira J, Sousa L, Ribeiro K, Sobrinho G, et al. [Complications of vascular access for hemodialysis-limits, imagination and commitment]. Rev Port Cir cardio-torácica e Vasc órgão Of da Soc Port Cir Cardio-Torácica e Vasc [Internet]. 20(4):211–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25202756
Yerdel MA, Kesenci M, Yazicioglu KM, Döşeyen Z, Türkçapar AG, Anadol E. Effect of haemodynamic variables on surgically created arteriovenous fistula flow. Nephrol Dial Transplant [Internet]. 1997 Aug;12(8):1684–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9269649
Robbin ML, Chamberlain NE, Lockhart ME, Gallichio MH, Young CJ, Deierhoi MH, et al. Hemodialysis arteriovenous fistula maturity: US evaluation. Radiology [Internet]. 2002 Oct;225(1):59–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12354984
Bashar K, Healy D, Browne LD, Kheirelseid EAH, Walsh MT, Clarke-Moloney M, et al. Role of far infra-red therapy in dialysis arterio-venous fistula maturation and survival: systematic review and meta-analysis. PLoS One [Internet]. 2014;9(8):e104931. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25115802
Santoro A, Canova C, Freyrie A, Mancini E. Vascular access for hemodialysis. J Nephrol [Internet]. 19(3):259–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16874684
Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int [Internet]. 2002 Oct;62(4):1109–24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12234281
Lok CE, Oliver MJ, Su J, Bhola C, Hannigan N, Jassal S V. Arteriovenous fistula outcomes in the era of the elderly dialysis population. Kidney Int [Internet]. 2005 Jun;67(6):2462–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15882293
Rayner HC, Pisoni RL, Gillespie BW, Goodkin DA, Akiba T, Akizawa T, et al. Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int [Internet]. 2003 Jan;63(1):323– 30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12472799
Rayner HC, Besarab A, Brown WW, Disney A, Saito A, Pisoni RL. Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines. Am J Kidney Dis [Internet]. 2004 Nov;44(5 Suppl 2):22–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15486870
Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, et al. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int [Internet]. 2002 Jan;61(1):305–16. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11786113
Allon M, Lockhart ME, Lilly RZ, Gallichio MH, Young CJ, Barker J, et al. Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients. Kidney Int [Internet]. 2001 Nov;60(5):2013–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11703621
Oliver MJ, McCann RL, Indridason OS, Butterly DW, Schwab SJ. Comparison of transposed brachiobasilic fistulas to upper arm grafts and brachiocephalic fistulas. Kidney Int [Internet]. 2001 Oct;60(4):1532–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11576369
Allon M. Current management of vascular access. Clin J Am Soc Nephrol [Internet]. 2007 Jul;2(4):786–800. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17699495
Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol [Internet]. 2004 Feb;15(2):477–86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14747396
End Stage Renal Disease Network Organization Program 2012 Summary Annual 39 Report [Internet]. Baltimore,: Centers for Medicare & Medicaid Services; 2014. Available from: http://esrdncc.org/wpcontent/ uploads/2014/10/SAR2012_FINAL_10_07_14.pdf
USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [Internet]. Bethesda: U.S. Renal Data System; 2010. Available from: http://www.usrds.org/adr.aspx
USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [Internet]. Bethesda: U.S. Renal Data System,; 2012. Available from: http://www.usrds.org/atlas12.aspx
Conte MS, Nugent HM, Gaccione P, Roy-Chaudhury P, Lawson JH. Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling. J Vasc Surg [Internet]. 2011 Nov;54(5):1383–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21840154
Salmela B, Hartman J, Peltonen S, Albäck A, Lassila R. Thrombophilia and arteriovenous fistula survival in ESRD. Clin J Am Soc Nephrol [Internet]. 2013 Jun;8(6):962–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23411429
Peterson WJ, Barker J, Allon M. Disparities in fistula maturation persist despite preoperative vascular mapping. Clin J Am Soc Nephrol [Internet]. 2008 Mar;3(2):437–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18235150
Rodriguez JA, Armadans L, Ferrer E, Olmos A, Codina S, Bartolomé J, et al. The function of permanent vascular access. Nephrol Dial Transplant [Internet]. 2000 Mar;15(3):402–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10692528
Lee T, Ullah A, Allon M, Succop P, El-Khatib M, Munda R, et al. Decreased cumulative access survival in arteriovenous fistulas requiring interventions to promote maturation. Clin J Am Soc Nephrol [Internet]. 2011 Mar;6(3):575–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21088288
Allon M, Litovsky S, Young CJ, Deierhoi MH, Goodman J, Hanaway M, et al. Medial fibrosis, vascular calcification, intimal hyperplasia, and arteriovenous fistula maturation. Am J Kidney Dis [Internet]. 2011 Sep;58(3):437–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21719173
Khavanin Zadeh M, Gholipour F, Naderpour Z, Porfakharan M. Relationship between Vessel Diameter and Time to Maturation of Arteriovenous Fistula for Hemodialysis Access. Int J Nephrol [Internet]. 2012;2012:942950. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22187645
Khavanin Zadeh M, Gholipour F, Hadipour R. The effect of hemoglobin level on arteriovenous fistula survival in Iranian hemodialysis patients. J Vasc Access [Internet]. 9(2):133–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18609530
Yilmaz H, Bozkurt A, Cakmak M, Celik HT, Bilgic MA, Bavbek N, et al. Relationship between late arteriovenous fistula (AVF) stenosis and neutrophillymphocyte ratio (NLR) in chronic hemodialysis patients. Ren Fail [Internet]. 2014 Oct;36(9):1390–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25246339
Acuña Merchán L, Soler Vanoy LA. Situación de la Enfermedad Renal Crónica en Colombia 2013 [Internet]. Bogotá: Cuenta de Alto Costo; 2013. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/INEC/CAC/SIT UACION_DE_LA_ENFERMEDAD_RENAL_CRONICA_2013.pdf
Jubran. Pulse oximetry. Crit Care [Internet]. 1999;3(2):R11–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11094477
Wukitsch MW, Petterson MT, Tobler DR, Pologe JA. Pulse oximetry: analysis of theory, technology, and practice. J Clin Monit [Internet]. 1988 Oct;4(4):290–301. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3057122
Wouters PF, Gehring H, Meyfroidt G, Ponz L, Gil-Rodriguez J, Hornberger C, et al. Accuracy of pulse oximeters: the European multi-center trial. Anesth Analg [Internet]. 2002 Jan;94(1 Suppl):S13–6. Available from: 41 http://www.ncbi.nlm.nih.gov/pubmed/11900030
Van de Louw A, Cracco C, Cerf C, Harf A, Duvaldestin P, Lemaire F, et al. Accuracy of pulse oximetry in the intensive care unit. Intensive Care Med [Internet]. 2001 Oct;27(10):1606–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17999668
Pulse oximeters. Health Devices [Internet]. 1989 Jun;18(6):185–99, 206–19, 222–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2485835
Clayton DG, Webb RK, Ralston AC, Duthie D, Runciman WB. Pulse oximeter probes. A comparison between finger, nose, ear and forehead probes under conditions of poor perfusion. Anaesthesia [Internet]. 1991 Apr;46(4):260–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2024741
Branson RD, Mannheimer PD. Forehead oximetry in critically ill patients: the case for a new monitoring site. Respir Care Clin N Am [Internet]. 2004 Sep;10(3):359– 67, vi – vii. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15458733
Fernandez M, Burns K, Calhoun B, George S, Martin B, Weaver C. Evaluation of a new pulse oximeter sensor. Am J Crit Care [Internet]. 2007 Mar;16(2):146–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17322015
Schallom L, Sona C, McSweeney M, Mazuski J. Comparison of forehead and digit oximetry in surgical/trauma patients at risk for decreased peripheral perfusion. Heart Lung [Internet]. 36(3):188–94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17509425
Ralston AC, Webb RK, Runciman WB. Potential errors in pulse oximetry. I. Pulse oximeter evaluation. Anaesthesia [Internet]. 1991 Mar;46(3):202–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2014898
Jubran A, Tobin MJ. Reliability of pulse oximetry in titrating supplemental oxygen therapy in ventilator-dependent patients. Chest [Internet]. 1990 Jun;97(6):1420–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2347228
Saito S, Fukura H, Shimada H, Fujita T. Prolonged interference of blue dye “patent blue” with pulse oximetry readings. Acta Anaesthesiol Scand [Internet]. 1995 Feb;39(2):268–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7793197
Comber JT, Lopez BL. Evaluation of pulse oximetry in sickle cell anemia patients presenting to the emergency department in acute vasoocclusive crisis. Am J Emerg Med [Internet]. 1996 Jan;14(1):16–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8630147
Coté CJ, Goldstein EA, Fuchsman WH, Hoaglin DC. The effect of nail polish on pulse oximetry. Anesth Analg [Internet]. 1988 Jul;67(7):683–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3382042
Rheineck-Leyssius AT, Kalkman CJ. Influence of pulse oximeter lower alarm limit on the incidence of hypoxaemia in the recovery room. Br J Anaesth [Internet]. 1997 Oct;79(4):460–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9389263
Le Bourdellès G, Estagnasié P, Lenoir F, Brun P, Dreyfuss D. Use of a pulse oximeter in an adult emergency department: impact on the number of arterial blood gas analyses ordered. Chest [Internet]. 1998 Apr;113(4):1042–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9554645
Solsona JF, Marrugat J, Vázquez A, Masdeu G, Alvárez F, Nolla J. Effect of pulse oximetry on clinical practice in the intensive care unit. Lancet (London, England) [Internet]. 1993 Jul 31;342(8866):311–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8101343
Jubran A. Pulse oximetry. Crit Care [Internet]. 2015;19:272. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26179876
No Title [Internet]. Available from: http://urgenciaspediatria.hospitalcruces.com/doc/generales/proto/Cap4.6_pulsioxime tria.pdf
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción. En Colombia, el 80% de los pacientes con enfermedad renal crónica en hemodiálisis tienen fístula arteriovenosa periférica (FAV) que asegura el flujo de sangre durante la hemodiálisis (1), la variabilidad en el flujo de sangre en e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12c6b56f4abaf9eca5607f46710bfb48
Publikováno v:
Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, et al. Fabry disease, an under-recognized multisystemic disorder: Expert recommendations for diagnosis, management, and enzyme replacement therapy. Annals of Internal Medicine. 2003. p. 338–46.
Ioannou YA, Zeidner KM, Gordon RE, Desnick RJ. Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice. Am J Hum Genet. 2001;68(1):14–25
Bishop DF, Kornreich R, Desnick RJ. Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3’ untranslated region. Proc Natl Acad Sci U S A. 1988;85(11):3903–7.
Redonnet-Vernhet I, Ploos van Amstel JK, Jansen RP, Wevers RA, Salvayre R, Levade T. Uneven X inactivation in a female monozygotic twin pair with Fabry disease and discordant expression of a novel mutation in the alpha-galactosidase A gene. Journal of medical genetics. 1996. p. 682–8.
Hasholt L, Sørensen SA, Wandall A, Andersen EB, Arlien-Søborg P. A Fabry’s disease heterozygote with a new mutation: biochemical, ultrastructural, and clinical investigations. Journal of medical genetics. 1990. p. 303–6.
Pabico RC, Atancio BC, McKenna BA, Pamukcoglu T, Yodaiken R. Renal pathologic lesions and functional alterations in a man with Fabry’s disease. Am J Med. 1973;55(3):415–25.
Desnick RJ, Blieden LC, Sharp HL, Hofschire PJ, Moller JH. Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies. Circulation. 1976. p. 818–25.
Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA. 1999;281(3):249–54.
Siamopoulos KC. Fabry disease: Kidney involvement and enzyme replacement therapy. Kidney International. 2004. p. 744–53.
Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry’s disease. Ceramidetrihexosidase deficiency. The New England journal of medicine. 1967.
Kornreich R, Desnick RJ, Bishop DF. Nucleotide sequence of the human alpha-galactosidase A gene. Nucleic Acids Res. 1989;17(8):3301–2.
Krawczak M, Ball E V, Fenton I, Stenson PD, Abeysinghe S, Thomas N, et al. Human gene mutation database-a biomedical information and research resource. Hum Mutat. 2000;15(1):45–51.
Dawson G, Sweeley CC. In vivo studies on glycosphingolipid metabolism in porcine blood. J Biol Chem. 1970;245(2):410–6.
Menkes DL. Images in neurology. The cutaneous stigmata of Fabry disease: an X-linked phakomatosis associated with central and peripheral nervous system dysfunction. Archives of neurology. 1999. p. 487.
Morgan SH, Rudge P, Smith SJ, Bronstein AM, Kendall BE, Holly E, et al. The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency)--investigation of symptomatic and presymptomatic patients. Q J Med. 1990;75(277):491–507.
Menkes DL, O’Neil TJ, Saenz KK. Fabry’s disease presenting as syncope, angiokeratomas, and spoke-like cataracts in a young man: discussion of the differential diagnosis. Military medicine. 1997. p. 773–6.
Onishi A, Dyck PJ. Loss of small peripheral sensory neurons in Fabry disease. Histologic and morphometric evaluation of cutaneous nerves, spinal ganglia, and posterior columns. Arch Neurol. 1974;31(2):120–7.
Cable WJ, Kolodny EH, Adams RD. Fabry disease: impaired autonomic function. Neurology. 1982;32(5):498–502.
Sher NA, Letson RD, Desnick RJ. The ocular manifestations in Fabry’s disease. Arch Ophthalmol. 1979;97(4):671–6.
Sheth KJ, Werlin SL, Freeman ME, Hodach AE. Gastrointestinal structure and function in Fabry’s disease. Am J Gastroenterol. 1981;76(3):246–51.
Kampmann C, Baehner F, Ries M, Beck M. Cardiac involvement in Anderson-Fabry disease. J Am Soc Nephrol. 2002;13 Suppl 2:S147–9.
Linhart A, Palecek T, Bultas J, Ferguson JJ, Hrudová J, Karetová D, et al. New insights in cardiac structural changes in patients with Fabry’s disease. Am Heart J. 2000;139(6):1101–8.
Sachdev B, Takenaka T, Teraguchi H, Tei C, Lee P, McKenna WJ, et al. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation. 2002;105(12):1407–11.
Mehta J, Tuna N, Moller JH, Desnick RJ. Electrocardiographic and vectorcardiographic abnormalities in Fabry’s disease. Am Heart J. 1977;93(6):699–705.
Goldman ME, Cantor R, Schwartz MF, Baker M, Desnick RJ. Echocardiographic abnormalities and disease severity in Fabry’s disease. J Am Coll Cardiol. 1986;7(5):1157–61.
Nagao Y, Nakashima H, Fukuhara Y, Shimmoto M, Oshima A, Ikari Y, et al. Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of alpha-galactosidase A. Clinical genetics. 1991. p. 233–7.
Mitsias P, Levine SR. Cerebrovascular complications of Fabry’s disease. Ann Neurol. 1996;40(1):8–17.
Mendez MF, Stanley TM, Medel NM, Li Z, Tedesco DT. The vascular dementia of Fabry’s disease. Dementia and geriatric cognitive disorders. p. 252–7.
Nakao S, Kodama C, Takenaka T, Tanaka A, Yasumoto Y, Yoshida A, et al. Fabry disease: Detection of undiagnosed hemodialysis patients and identification of a “renal variant” phenotype. Kidney Int. 2003;64(3):801–7.
Largent EA, Pearson SD. Which orphans will find a home? The rule of rescue in resource allocation for rare diseases. Hastings Cent Rep. 2012;42(1):27–34.
Jonsen AR. Bentham in a box: technology assessment and health care allocation. Law Med Health Care. 1986;14(3-4):172–4.
Waldek S, Feriozzi S. Fabry nephropathy: a review-how can we optimize the management of Fabry nephropathy? BMC Nephrol [Internet]. 2014;15(1):72. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4029839&tool=pmcentrez&rendertype=abstract
Romão EA, Lourenço CM, Júnior WM, Rolfs A, Muñoz V, Neto OMV, et al. What lies beneath: Fabry nephropathy in a female patient with severe cerebrovascular disease. Clinical Nephrology. 2012.
Eng CM, Fletcher J, Wilcox WR, Waldek S, Scott CR, Sillence DO, et al. Fabry disease: Baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry. J Inherit Metab Dis. 2007;30(2):184–92.
Ardila Cardenas Maria Elizabeth MS. Prevalencia de la enfermedad de Fabry en hombres con Insuficiencia Renal Cronica en Unidades Renales de RTS Colombia. Cat Univ del Rosario. 2008
Kalkan Uçar S, Sozmen E, Duman S, Başçi A, Çoker M. Alpha-Galactosidase A Activity Levels in Turkish Male Hemodialysis Patients. Ther Apher Dial. 2012;16(6):560–5.
Terryn W, Cochat P, Froissart R, Ortiz A, Pirson Y, Poppe B, et al. Fabry nephropathy: Indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice. Nephrology Dialysis Transplantation. 2013. p. 505–17.
“Rare Diseases: understanding this Public Health Priority” [Internet]. Understanding this Public Health Priority-Eurordis. 2005. Available from: www.eurordis.org/IMG/.../princeps_document-EN.p...
Goolsby MJ. National Kidney Foundation Guidelines for chronic kidney disease: evaluation, classification, and stratification. J Am Acad Nurse Pract. 2002;14(6):238–42.
Miners AH, Holmes A, Sherr L, Jenkinson C, MacDermot KD. Assessment of health-related quality-of-life in males with Anderson Fabry Disease before therapeutic intervention. Qual Life Res. 2002;11(2):127–33.
Hwu WL, Chien YH, Lee NC, Chiang SC, Dobrovolny R, Huang AC, et al. Newborn screening for fabry disease in taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A). Hum Mutat. 2009;30(10):1397–405.
Maixnerová D, Tesař V, Ryšavá R, Reiterová J, Poupětová H, Dvořáková L, et al. The coincidence of IgA nephropathy and Fabry disease. BMC Nephrol [Internet]. 2013;14:6. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3549770&tool=pmcentrez&rendertype=abstract
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Ioannou YA, Zeidner KM, Gordon RE, Desnick RJ. Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice. Am J Hum Genet. 2001;68(1):14–25
Bishop DF, Kornreich R, Desnick RJ. Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3’ untranslated region. Proc Natl Acad Sci U S A. 1988;85(11):3903–7.
Redonnet-Vernhet I, Ploos van Amstel JK, Jansen RP, Wevers RA, Salvayre R, Levade T. Uneven X inactivation in a female monozygotic twin pair with Fabry disease and discordant expression of a novel mutation in the alpha-galactosidase A gene. Journal of medical genetics. 1996. p. 682–8.
Hasholt L, Sørensen SA, Wandall A, Andersen EB, Arlien-Søborg P. A Fabry’s disease heterozygote with a new mutation: biochemical, ultrastructural, and clinical investigations. Journal of medical genetics. 1990. p. 303–6.
Pabico RC, Atancio BC, McKenna BA, Pamukcoglu T, Yodaiken R. Renal pathologic lesions and functional alterations in a man with Fabry’s disease. Am J Med. 1973;55(3):415–25.
Desnick RJ, Blieden LC, Sharp HL, Hofschire PJ, Moller JH. Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies. Circulation. 1976. p. 818–25.
Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA. 1999;281(3):249–54.
Siamopoulos KC. Fabry disease: Kidney involvement and enzyme replacement therapy. Kidney International. 2004. p. 744–53.
Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry’s disease. Ceramidetrihexosidase deficiency. The New England journal of medicine. 1967.
Kornreich R, Desnick RJ, Bishop DF. Nucleotide sequence of the human alpha-galactosidase A gene. Nucleic Acids Res. 1989;17(8):3301–2.
Krawczak M, Ball E V, Fenton I, Stenson PD, Abeysinghe S, Thomas N, et al. Human gene mutation database-a biomedical information and research resource. Hum Mutat. 2000;15(1):45–51.
Dawson G, Sweeley CC. In vivo studies on glycosphingolipid metabolism in porcine blood. J Biol Chem. 1970;245(2):410–6.
Menkes DL. Images in neurology. The cutaneous stigmata of Fabry disease: an X-linked phakomatosis associated with central and peripheral nervous system dysfunction. Archives of neurology. 1999. p. 487.
Morgan SH, Rudge P, Smith SJ, Bronstein AM, Kendall BE, Holly E, et al. The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency)--investigation of symptomatic and presymptomatic patients. Q J Med. 1990;75(277):491–507.
Menkes DL, O’Neil TJ, Saenz KK. Fabry’s disease presenting as syncope, angiokeratomas, and spoke-like cataracts in a young man: discussion of the differential diagnosis. Military medicine. 1997. p. 773–6.
Onishi A, Dyck PJ. Loss of small peripheral sensory neurons in Fabry disease. Histologic and morphometric evaluation of cutaneous nerves, spinal ganglia, and posterior columns. Arch Neurol. 1974;31(2):120–7.
Cable WJ, Kolodny EH, Adams RD. Fabry disease: impaired autonomic function. Neurology. 1982;32(5):498–502.
Sher NA, Letson RD, Desnick RJ. The ocular manifestations in Fabry’s disease. Arch Ophthalmol. 1979;97(4):671–6.
Sheth KJ, Werlin SL, Freeman ME, Hodach AE. Gastrointestinal structure and function in Fabry’s disease. Am J Gastroenterol. 1981;76(3):246–51.
Kampmann C, Baehner F, Ries M, Beck M. Cardiac involvement in Anderson-Fabry disease. J Am Soc Nephrol. 2002;13 Suppl 2:S147–9.
Linhart A, Palecek T, Bultas J, Ferguson JJ, Hrudová J, Karetová D, et al. New insights in cardiac structural changes in patients with Fabry’s disease. Am Heart J. 2000;139(6):1101–8.
Sachdev B, Takenaka T, Teraguchi H, Tei C, Lee P, McKenna WJ, et al. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation. 2002;105(12):1407–11.
Mehta J, Tuna N, Moller JH, Desnick RJ. Electrocardiographic and vectorcardiographic abnormalities in Fabry’s disease. Am Heart J. 1977;93(6):699–705.
Goldman ME, Cantor R, Schwartz MF, Baker M, Desnick RJ. Echocardiographic abnormalities and disease severity in Fabry’s disease. J Am Coll Cardiol. 1986;7(5):1157–61.
Nagao Y, Nakashima H, Fukuhara Y, Shimmoto M, Oshima A, Ikari Y, et al. Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of alpha-galactosidase A. Clinical genetics. 1991. p. 233–7.
Mitsias P, Levine SR. Cerebrovascular complications of Fabry’s disease. Ann Neurol. 1996;40(1):8–17.
Mendez MF, Stanley TM, Medel NM, Li Z, Tedesco DT. The vascular dementia of Fabry’s disease. Dementia and geriatric cognitive disorders. p. 252–7.
Nakao S, Kodama C, Takenaka T, Tanaka A, Yasumoto Y, Yoshida A, et al. Fabry disease: Detection of undiagnosed hemodialysis patients and identification of a “renal variant” phenotype. Kidney Int. 2003;64(3):801–7.
Largent EA, Pearson SD. Which orphans will find a home? The rule of rescue in resource allocation for rare diseases. Hastings Cent Rep. 2012;42(1):27–34.
Jonsen AR. Bentham in a box: technology assessment and health care allocation. Law Med Health Care. 1986;14(3-4):172–4.
Waldek S, Feriozzi S. Fabry nephropathy: a review-how can we optimize the management of Fabry nephropathy? BMC Nephrol [Internet]. 2014;15(1):72. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4029839&tool=pmcentrez&rendertype=abstract
Romão EA, Lourenço CM, Júnior WM, Rolfs A, Muñoz V, Neto OMV, et al. What lies beneath: Fabry nephropathy in a female patient with severe cerebrovascular disease. Clinical Nephrology. 2012.
Eng CM, Fletcher J, Wilcox WR, Waldek S, Scott CR, Sillence DO, et al. Fabry disease: Baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry. J Inherit Metab Dis. 2007;30(2):184–92.
Ardila Cardenas Maria Elizabeth MS. Prevalencia de la enfermedad de Fabry en hombres con Insuficiencia Renal Cronica en Unidades Renales de RTS Colombia. Cat Univ del Rosario. 2008
Kalkan Uçar S, Sozmen E, Duman S, Başçi A, Çoker M. Alpha-Galactosidase A Activity Levels in Turkish Male Hemodialysis Patients. Ther Apher Dial. 2012;16(6):560–5.
Terryn W, Cochat P, Froissart R, Ortiz A, Pirson Y, Poppe B, et al. Fabry nephropathy: Indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice. Nephrology Dialysis Transplantation. 2013. p. 505–17.
“Rare Diseases: understanding this Public Health Priority” [Internet]. Understanding this Public Health Priority-Eurordis. 2005. Available from: www.eurordis.org/IMG/.../princeps_document-EN.p...
Goolsby MJ. National Kidney Foundation Guidelines for chronic kidney disease: evaluation, classification, and stratification. J Am Acad Nurse Pract. 2002;14(6):238–42.
Miners AH, Holmes A, Sherr L, Jenkinson C, MacDermot KD. Assessment of health-related quality-of-life in males with Anderson Fabry Disease before therapeutic intervention. Qual Life Res. 2002;11(2):127–33.
Hwu WL, Chien YH, Lee NC, Chiang SC, Dobrovolny R, Huang AC, et al. Newborn screening for fabry disease in taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A). Hum Mutat. 2009;30(10):1397–405.
Maixnerová D, Tesař V, Ryšavá R, Reiterová J, Poupětová H, Dvořáková L, et al. The coincidence of IgA nephropathy and Fabry disease. BMC Nephrol [Internet]. 2013;14:6. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3549770&tool=pmcentrez&rendertype=abstract
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción: La Enfermedad de Fabry (EF), es una enfermedad multisistémica de almacenamiento lisosomal ligada al cromosoma X que afecta principalmente a hombres, pero también puede causar significativa morbilidad en las mujeres heterocigotas (1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce9a170727e9f54e9747f8188bacadff